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Black women in the United States suffer disproportionately from a number of chronic 
and acute diseases. Not only do black women suffer from these diseases, they also have poorer 
outcomes and higher levels of morbidity and mortality than others. Years of biomedical and 
social science research have identified various permutations of patient-level factors, including 
cultural mistrust and genetic predisposition, to explain the existence of this race and gender-
specific reality. However, few studies have looked at physician-level influences on poor health 
results for black women. 
Through the use of face-to-face and internet-based instruments combining patient 
vignettes and closed and open-ended treatment questions, the Implicit Association Test (IAT) 
and a series of measures of explicit discriminatory beliefs, this study used the case of Systemic 
Lupus Erythematosus (SLE) to illustrate how and whether decisions about medical treatment and 
follow-up for black women patients differ from decisions made for white women patients in 
varying degrees according to: the patient´s race; the severity of symptoms; the physician’s 
perception of the patient’s personal characteristics (e.g., personality, mood); the physician’s 
demographic characteristics; and the physician´s score on the discriminatory belief measures 
named above. The study has collected data from 94 rheumatologists. 
The study enabled the assessment of differences in treatment recommendations for 




involvement for people with SLE. The only difference between the patients seen by the doctors 
through the study was their race, black or white, so the study asked whether treatment 
recommendations were significantly different for black patients as compared to white patients. 
The study also asked whether these treatment decisions could be predicted by scores on a series 
of measures of implicit (unconscious) and explicit racial bias.  Overall, this study did not find 
evidence that physicians recommended less optimal treatment to black patients.  Several possible 
reasons for the non-significant findings are discussed. 
The thesis recommends further study and intervention into the identification and 
treatment of early symptoms of disease among black women to reduce the incidence of avoidable 
morbidity and mortality in this population. These studies should as well take into account the 
possibility that over-compensatory behaviors may be exhibited by physician study participants 
who suspect that their racism or discriminatory beliefs may be revealed through their responses. 
New methods to obscure explicit and implicit discriminatory measures and to reduce the threat of 
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CHAPTER 1: INTRODUCTION 
 
Black women along with Indigenous women in the United States and elsewhere in the 
hemisphere, have the poorest health indicators for reproductive health and infectious and chronic 
disease
1
 [1]. One clear explanation for race-based differences in health outcomes is explained by 
the fact that black people in the United States receive lower quality and fewer health services that 
do white Americans, even when insurance status, income, age and co-morbidities are taken into 
account [2]. It is also true that in many cases, black women receive and seek attention at later 
stages of disease than do other women and men, a factor that leads often to higher mortality from 
diseases deemed easily treated when caught in their early stages [3]. Various cultural, 
socioeconomic, genetic and information asymmetry theories have been forwarded to explain 
gender and race specific health disparities
2
 [4-6] and each study has found some evidence for the 
salience of a variety of factors as contributors to poorer health outcomes for black women. For 
example, Sharpe, et. al. [5] discuss the influences of poverty, loss of gender power and 
restructured families as among the causes of black women’s increased risk of exposure to 
HIV/AIDS in the United States.  
But in 1999, Schulman et. al. published the results of an experimental study, “The Effects 
of Race and Sex on Physicians’ Recommendations for Cardiac Catheterization” in which they 
                                                          
1
 A 2005 Agency for Healthcare Research and Quality report found that white patients received better quality of care 
that 53% of Hispanic, 43% of African American, 38% of American Indian/Alaska Native and 22% of Asian/Pacific 
Islander patients 1. Quality, A.f.H.R.a., National Healthcare Disparities Report. 2005, US Department of 








reported the results of a study of cardiologists that used scripted video vignettes to control for 
patients’ medical histories and personalities. The study found that “the race and sex of the patient 
affected the physicians’ decisions about whether to refer patients with chest pain for cardiac 
catheterization... [the] findings are most striking for black women.”  The study highlighted  a 
chronic disease for which black women suffer higher morbidity and mortality than white women,  
for which black women received less efficacious treatment recommendations than did other 
groups by race and sex. This was a disparity in early intervention specific to black women that 
could explain in part black women’s higher morbidity and mortality from cardiovascular disease, 
yet the authors offered little explanation beyond the suggestion that conscious or more likely 
unconscious bias may play a role the differences seen in treatment recommendation.  In the years 
since, no other researchers have taken up the challenge posed by Shulman et. al.’s “striking” 
findings. In fact, none of the 51 articles written about black women and cardiac health
3
 since 
2000 examines the possible impact of physician bias on poor cardiac outcomes for black women. 
The focus of cardiovascular disease study remains on health behaviors, an undoubtedly 
important factor in preventing and ameliorating symptoms of cardiac dysfunction.  
The same “overlooking” of physician-level factors in disparity is true for many of the 
other diseases from which black women suffer disproportionately. In the wider medical literature 
on health disparities, most of the focus continues to be on perceptions of discrimination among 
patients and, to a smaller extent, on physician’s unconscious racial perceptions [7]. According to 
Shaver et al. [7] “additional research is needed that explores whether and under what conditions 
the implicit attitudes of providers affect the quality of the medical care delivered to racial/ethnic 
                                                          
3
 PubMed search “((black women[Title]) OR African American women[Title]) AND cardiac AND 




minority patients.” It is here, with physician-focused explanations for black women’s health 
disparities that the present research begins, supported by sociological and biomedical findings of 
unequal treatment by race during the medical encounter [7-15]. 
In an effort to fill the gap in the understanding of how physician bias contributes to health 
disparities, through this research study I surveyed 101 rheumatologists to discern whether 
implicit or explicit racial bias translates into discriminatory behavior. Specifically, the study 
presented these physicians with a randomly selected patient photo of a black or white patient and 
a randomly assigned written vignette describing the patient’s symptoms. In one vignette, the 
patient presents with a series of acute or ambiguous symptoms of lupus nephritis (LN), a 
common kidney-related side effect for people with Systemic Lupus Erythematosus (SLE) that 
can lead to end stage renal failure (ESRD). In the second description, the patient presents with 
symptoms that can be interpreted as a more severe LN complaint. After reading his or her 
patient’s symptoms, the physicians were asked to recommend prescription additions or changes, 
further testing, follow-up visit times and specialist referral. Physicians were then asked to 
comment on the availability of relevant testing and other medical interventions for patients in 
their practice, followed by items that asked the physician to assess the personal characteristics of 
his or her patient. Among the characteristics assessed were: intelligence; compliance; and 
knowledge. Finally, physicians completed tests that measured their implicit and explicit bias 
toward and against low status groups, specifically blacks, in the United States. The goal of the 
study was to explain physicians’ decision making processes and treatment recommendations for 
women patients with a possible complication of SLE, lupus nephritis, when those patients 




In the next chapter, I present a review of the literature on the central concepts behind this 
experiment’s hypotheses. First, I look at the historical significance of racism and health 
disparities in the United States. Then, I focus on racial stereotypes and stigma and the relation of 
these to poor health and health care for African Americans, highlighting the literature on racial 
bias in medical encounters. Finally, I review the literature on power dynamics in the medical 
interaction in order to bring context to the experiment.  
In Chapter Three, I outline the two methods for collecting data for the study, detailing 
especially the face-to-face data collection carried out at the American College of Rheumatology 
(ACR) meetings in November of 2011; methods used to recruit participants; the characteristics 
of the study sample; and the composition of the independent and dependent variables used in the 
study. I also describe the statistical methods used to analyze the data collected and power 
calculations for the study’s central hypothesis, that black women patients receive less optimal 
treatment recommendations than do white women patients, and present a detailed explanation of 
the study’s hypotheses. 
Chapter Four describes the findings of the data analysis. Finally, in Chapter Five, I 








The causes and consequences of the post-Civil War United States’ racial hierarchy have 
been well documented.  Marx [16] concludes that “the conflict-ridden process of nation-state 
consolidation [in the United States] set the terms of official racial domination…Earlier racial 
discrimination and the racist ideology developed to defend it were encoded or allowed by state 
action to reinforce institutional power and white loyalty to it. Legal exclusion of blacks helped to 
gradually unify the core constituency of whites.”   Du Bois and Frazier documented and analyzed 
first-hand the effects of the resulting system on the black population in the United States. 
Comparing the racial structure in the United States to a caste system, Frazier states that “it was 
accomplished by reducing public education for Negroes, by disfranchising [sic] them politically, 
and by instituting a system of racial segregation or Jim Crow. All these measures tended to 
restrict Negroes to certain occupations”[17] and create for them colonies within the larger white 
nation.   
Fifty years after Frazier, and following the passage of the Civil Rights Act of 1964 that 
eliminated legal separation of the races, scholars and activists continued to draw parallels 
between the situation of blacks in the United States and that of colonized nations [18]. Black race 
in the United States persisted as a primary de facto indicator of low caste status [19, 20], 
although the verbalization of such beliefs had become taboo [21]. Belief in the pre-Civil Rights 




as new forms of racism were identified. Among the new conceptions
4
 of  post-Civil Rights 
racism was modern racism [21], one manifestation of which is aversive racism [23]. 
Modern (or Symbolic) Racism is described most often as: 
a coherent belief system combining the following ideas: that racial discrimination 
is no longer a serious obstacle to blacks’ prospects for a good life; that blacks’ 
continuing disadvantages are due to their own unwillingness to take responsibility 
for their lives; and that, as a result, blacks’ continuing anger about their own 
treatment, and the various kinds of special attention given to them are not truly 
justified…These beliefs come out of what has been known as a psychological 
‘blend’ of negative affect directed against blacks with conservative values, 
particularly the belief that blacks violate cherished American values.” [24] 
Dovidio and Gaertner add to this lexicon an explanation for race-based avoidant 
behaviors displayed by whites who claim to be non-racist. They term this behavior aversive 
racism—“the racial attitudes of many whites who endorse egalitarian values …[and] regard 
themselves as non-prejudiced, but who discriminate in subtle, rationalizable ways” [25]. The 
effects of aversive racism are most often demonstrated where “nonprejudiced” whites are forced 
to make decisions in situations in which “bias is not obvious or can be rationalized on the basis 
of some factor other than race
5
.”  They go on to site the results of a laboratory study of helping 
behavior of whites in which individuals in one group are led to believe that he or she is the only 
witness to an emergency involving a black or white victim. Members of a second group are led 
to believe that there are other witnesses to the emergency. Members of group one, sole witnesses, 
frequently helped both black and white victims “(over 85% of the time) and equivalently. There 
                                                          
4
 Other definitions of post-Civil Rights racism include: symbolic racism; ideological refinement; and laissez-faire 
racism. 22. Quillian, L., New Approaches to Understanding Racial Prejudice and Discrimination Annual 
Review of Sociology, 2006. 32(299-328): p. 299. 
 
5
 The same behavior has been proven true for sexist behavior, where factors other than gender are used to rationalize 
the exclusion of women 26. Swim, J.K. and L.L. Cohen, Overt, covert, and subtle sexism. Psychology of 




was no evidence of blatant racism. In contrast, when they thought there were other witnesses and 
they could rationalize a decision not to help on the basis of some other factor other than race, 
they helped Black victims only half as often as White victims (37.5% vs. 75%)” [27]. Similarly, 
Dovidio and Gaerter report another set of results of an experiment involving 194 undergraduate 
students who responded to questionnaires assessing their racial attitudes, then were asked to 
evaluate fictional applicants for a peer counseling position. They found that “moderate 
qualifications are responded to as if they were strong qualifications when the candidate is white, 
but as if they were weak qualifications when the candidate is black…these biases reflect in-group 
favoritism and out-group derogation”[25]. It is also important to note that class plays a central 
role in the application of these assignations of racist belief, with well-educated whites associated 
more closely with aversive racist behaviors and working class whites with Old-Fashioned 
Racism. 
 Dovidio and Gaertner’s work comes the closest of all explanations of how racism 
“works” in modern day life: well-meaning whites who often report very egalitarian beliefs 
discriminate due to conscious and unconscious bias against blacks. The aversive racism thesis 
puts a mechanism to that discrimination, identifying it as most likely when factors other than 
race can be blamed for differentiation between actions that benefit whites and disadvantage 
blacks. Jones’ framework for understanding racism affords the racism concept three levels: 
institutionalized, that includes “material conditions and access to power”; personally mediated, 
meaning “differential assumptions about the abilities, motives, and intentions of others according 
to their race…and differential actions toward others according to their race”; and internalized, 
“acceptance by members of the stigmatized races of negative messages about their own abilities 




that the literature attributes aversive racism to unconscious rather than conscious bias.  Though 
whites are the main object of study in this area, non-whites, including blacks, who take measures 
of implicit bias, also display anti-black bias [14]. 
Health Disparities  
 
Racism and social discrimination harm health [29, 30]. In the United States, blacks suffer 
disproportionately from both chronic and acute illnesses and are disproportionately represented 
among victims of violence [30]. We know that for many causes of morbidity and mortality 
“women of color are significantly worse off than white women” [31, 32]. Black women have 
higher incidences, morbidity and mortality from obesity; diabetes; hypertension and other 
cardiovascular disease; uterine fibroids; Systemic Lupus Erythematosus; and low birth weight 
pregnancies than do whites [33, 34]. Krieger identifies the study of the health impacts of racism 
as a central component in unpacking and solving this omnipresent social inequality in American 
life [35], but also concedes that measurements of the harms of discrimination and racism is 
neither an easy nor a straight forward task [35, 36]. There have been many methods employed in 
the study of the effect of race, racism and racial discrimination on health, health care and health 
outcomes for blacks in the United States. These studies explore, among other areas, the impacts 
of genetics, compliance, trust in physicians, socioeconomic status and physician biases in their 
attempt to create a picture of the exact harms done to the health of African Americans due to 
their own biology, cultural practices and beliefs or the workings of the society at large. 
Genetic studies into the impact of race on health forward the idea that the diseases with 
which blacks suffer disproportionately are biologically determined. For example, genetic factors 




African Americans [37-39] have been recent topics of study, while little reference is made to the 
environmental factors that have also been identified as likely causes for higher incidence of these 
diseases in black populations (e.g., residential segregation, as black communities are often 
located in inner cities with poor air and housing quality [40, 41]; inequities in pre-transplant care 
and access to transplant centers [42]; and use of hair relaxers [43].  
The search for the genetic underpinnings of health disparities for blacks has a long 
history in the United States. In the late 19
th
 century, diseases from which blacks seemed to suffer 
disproportionately were deemed “black” diseases and were considered evidence of “inherent 
black frailty”, inferiority  and immutable elements of blacks’ evolutionary lot  [44]. Later, 
eugenic theories provided more support for the most widely accepted explanations for 
differences in disease burden by race:    
Between 1900 and 1910, geneticists discovered human traits that adhered to a 
Mendelian pattern of inheritance, one in which the breeding of two carrier parents 
resulted in a mathematically predictable mixture of well, ill and carrier 
offspring…Armed with this knowledge, Galton first formulated the desirability of 
using selective procreation to refine the human race while conquering social 
dysfunction…African Americans were roundly disparaged by eugenic theory as 
scientists continued to seek and find wide physiologic evidence of black 
inferiority…Even a cursory glance at the [eugenic hygiene] charts, photographs, 
and diagrams used to popularize eugenic ideals reveals that the unfit were 
“swarthy” “black” and ugly by Anglo-Saxon standards, with flattened noses, wiry 
black hair , and prognathous profiles” [44]. 
Washington comments that “this tendency to see environmentally and socially triggered 
illnesses as inherent defects of blacks is a troubling persistent trend in American medical 
research” [44]. The advent of health disparities research the 1990s has led to an exploration of 
social and cultural explanations for the disparate health outcomes seen between blacks and 




research in the United States, whose focus lies mainly in patient-oriented explanations. Then, I 
examine biomedical studies that have explored whether physicians’ biases may be responsible 
for differences by race in use of life-saving interventions.   
Since the mid-1990s the concepts and consequences of racism, sexism, and other “isms” 
in the medical realm have been subsumed under the term health disparities, a term that describes 
differences “in health and health care, where health refers to the status of an individual’s 
condition (i.e., the presence of a health condition or illness, such as high blood pressure, asthma, 
overweight, drug use) and health care refers to the process of treating an illness or injury. Some 
disparities may be inequitable, but not all are”[45].  Inequitable health disparities are sometimes 
referred to as health inequalities or negative health disparities in the literature, but as the 
prevailing bent to health disparities research is toward inequity, most often the term health 
disparities is considered synonymous with the negative connotation.  
Public health research on health disparities reached a fever pitch in the late 1990s and 
early 2000s following closely the economic, political science and sociological work on income 
inequality within and among countries and across social domains including employment, 
education, housing, health; and social stratification [46-49]. In one of the earliest statements 
defining the health disparities movement, “Social Conditions as Fundamental Causes of 
Disease,” Link and Phelan assert that socioeconomic status (SES), treated largely until that time 
as a confounding variable in risk factor–based epidemiologic research, must be evaluated 
contextually rather than tangentially if we are to understand the distribution of disease. In 
addition to contextualizing, they suggest that researchers take into account the “fundamental 




the elimination of the mechanisms that link these causes to disease [50]. For Link and Phelan, 
class (in conjunction with gender and race/ethnicity) is the most important “fundamental cause” 
of inequality in the United States, deserving of independent attention by public health problem-
solvers.  They conclude:  
Specifically, if the social factor is a fundamental cause, one cannot claim to have 
accounted for its effects by having ‘explained’ its association with the inclusion of 
intervening variables in a path or regression model. Second, to understand associations 
between fundamental causes and disease, medical sociologists need to examine the 
broader determinants of the resources that fundamental causes entail. This distinctly 
sociological enterprise will link medical sociologists to the broader discipline in a 
productive way as we seek to understand how general resources like knowledge, money, 
power, prestige, and social connections are transformed into the health-related resources 
that generate patterns of morbidity and mortality [50]. 
 
 An additional theoretical consideration is offered by House who details the move in 
social epidemiology from “a broad and continuing effort to understand social factors in health 
toward an increasing focus on understanding social inequalities in health” [51]. He reports that 
the result of this shift has been the legitimizing of the importance of psychosocial variables as 
“hard end points [in the understanding of] disease incidence or mortality” [51]. The psychosocial 
variables he delineates are:  race/ethnicity; gender; and socioeconomic status (to which the prior 
also contribute).  
As a result of the previously described theories and related research,  national public 
health priorities turned toward testing and identifying the central aspects of class, gender and 
race/ethnicity that are most relevant to addressing the health of disadvantaged groups in the U.S. 




Health and Human Services’ (DHHS) Healthy People 2010, “a long-term national agenda aimed 
at improving health in the United States” [45], named elimination of health disparities across 
gender, race, ethnicity, education, income, geography and sexual orientation as one of its two 
main goals
6
. At the international level, the Pan American Organization (PAHO) has also issued 
goals for the study and eradication of health inequalities based on poverty, education, ethnicity 
and gender [57]. Finally, it is also widely understood that the fulfillment of the Millennium 
Development Goals (MDGs) will require a concerted effort to address disparities in health [58]. 
Biomedical Research on Bias in Medical Encounters 
 
Almost simultaneous to the wave of publication around social science based health 
disparities, non-genetic, biomedical studies into the disparities question began to increase in 
number. To date, the most groundbreaking clinical work on the results of racism, sexism and 
classism on health has been through studies of cardiovascular disease (CVD) and coronary heart 
disease (CHD) [59-62]. These studies have found that women, as a group, and blacks, as a group, 
are often overlooked as candidates for potentially life-saving interventions and receive lower 
quality care than whites. Schulman, et. al. measured physicians’ propensity to refer patients for 
cardiac catheterization by patient race and gender.  Patient confederates were presented to 
physicians in video vignettes in which scripts and performances were strictly controlled and all 
patients had the same income, insurance coverage and personality affects. The study found that 
physicians were least likely to refer black women for the procedure:  
                                                          
6
 The first goal of Health People 2010 is “to help individuals of all ages increase life expectancy and improve their 
quality of life” 56. U.S. Department of Health and Human Services, Healthy People 2010: Understanding 




our finding that the race and sex of the patient influence the recommendations of 
physicians independently of other factors may suggest bias on the part of the 
physicians. However, our study could not assess the form of bias…. [it] may 
represent overt prejudice on the part of physicians or…could be the result of 
subconscious perceptions rather than deliberate actions or thoughts. Subconscious 
bias occurs when a patient’s membership in a target group automatically activates 
a cultural stereotype in the physician’s memory regardless of the level of 
prejudice the physician has [61]. 
In the Schulman study, black women specifically suffer the consequences of this medical 
bias. It should then follow that in this case at least some of the unconscious negative affect held 
by these physicians is toward women in general and black women in particular.  But this brief 
explanation of physician bias is insufficient to elucidate the variety of factors that influence 
physicians’ decision making. One factor highlighted in the prediction of physician’s decision 
making in the literature is physician characteristics (e.g., length of experience; medical specialty; 
race; gender; and personality) [63-66].  
Sabin et. al. explore “whether: 1) [they] would find differences in quality of care by 
patient race using case vignettes; and 2) strength of implicit race bias would be related to quality 
care” [65] for pediatric patients.  The web-based study, conducted with pediatric faculty, fellows, 
and residents from one department at a research university, presented the Race Attitude Implicit 
Association Test (IAT); the Race and Compliant Patient IAT; and the Race and Quality of 
Medical Care IAT as measures of implicit discriminatory beliefs.  Participants were also asked to 
respond to two explicit bias measures: “’My feelings towards African Americans are…’ and ‘My 
feelings towards European Americans are…’ (Answer options ranged from 0 = cold to 10 = 
warm)” [65].  Finally, participants were presented with two of four possible pediatric case 
vignettes in which patient confederates were either “(African American (sic) [or]…white) to 




control, management of urinary tract infection (UTI), Attention Deficit Hyperactivity Disorder, 
and asthma control”[65]. Following the vignettes, participants were asked to indicate the 
appropriateness of a series of treatment options using a 5-item Likert scale that ranged from: I 
strongly disagree, this is clearly the wrong treatment option to I strongly agree. This is clearly a 
good treatment option.  One of the treatment options presented represented ideal care for the case 
depicted but none of the options represented negligent or inadequate care. In their analysis, the 
authors find little evidence of overall implicit bias as measured by responses to the IAT tests 
administered, but mild implicit stereotypes about race and compliance skewed toward African 
Americans who were conceived as more compliant that European American patients (76% 
versus 19%)  and more likely to receive “preferred” medical care (88% versus 0%). The authors 
also found that participants “identified the ideal treatment recommendation more frequently for 
all cases except for asthma care…[and] there was no significant difference in recommendation 
differences by patient race except for management of UTI (for which African American received 
ideal care more often than whites)” [65].  The study concludes that the small sample size, use of 
a convenience sample, a physician sample skewed toward women, and the newness of the 
Compliant Patient IAT and the Quality of Medical Care IAT may have influenced their findings. 
A third study conducted by Green et al, asked 202 internal and emergency medical 
residents in four academic medical hospitals in Massachusetts and Georgia to consider a written 
patient vignette and photograph of a 50-year old man suffering chest pain. Participants were 
asked to read the vignette and indicate whether they would recommend thrombolysis (clot 
busting techniques) and to specify the strength of their recommendation. Physician participants 
were then asked to comment on their patient’s personal characteristics (e.g., patient 




Association Tests (IATs). The study found that physicians exhibited slight pro-white bias and 
that they indicated the need for thrombolysis equally between black and white patients. The 
authors underline that in the face of black men’s increased likelihood of coronary artery disease, 
equal treatment constitutes a disparity.   They also found that respondents with higher IAT scores 
(more pro-white bias) were less likely to recommend thrombolysis to black patients [67]. In sum, 
two of the three studies described above found racial bias in physician’s decision making and 
stereotyping of patients. However, the results of each of the studies underlined the complicated 
nature of physicians’ decision making about treatment and highlights the importance of data 
collection method, as the two studies conducted face-to-face at professional medical conferences 
seemed to obtain results closer to their hypotheses and to the known data on health disparities.  
Studies of patient perceptions of racial bias have also led to the conclusion that 
physicians’ implicit and explicit biases may play an important role in health disparities, but the 
studies have failed to include measures of racial bias among their analysis variables. For 
example, Berrios-Rivera, et. al. [68] measure Rheumatoid Arthritis (RA) and Systemic Lupus 
Erythematosus (SLE) patients’ trust in physicians as a general category (rather than trust in an 
individual provider), based on previous findings that increased trust is “significantly correlated 
with fewer side effects and better global health”[68]. The study finds that for the RA and SLE 
participants “trust in physicians is significantly and independently associated with patient’s 
ethnicity and specific components of physicians’ communicative style, including amount of 
information given, sensitivity to concerns, and patient-centeredness”. Specifically, they find 
lower levels of trust in physicians among African American and Latino participants as compared 
with whites; “the relationship between ethnicity and trust remains significant after controlling for 




In explanation, Berrios, et. al. suggests that “perhaps physicians (and/or patients) have 
subconscious biases, stereotypes, perceptions, or misconceptions…that interfere with open 
communication, empathy, and the development of trust”. They base this hypothesis on studies of 
cardiovascular disease (CVD) and coronary heart disease (CHD) summarized above.  
Cruz-Flores et al reviewed the stroke care literature from 1972 to 2010 and found 
differences in the burden of stroke risk and stroke care between racial and ethnic minorities in 
the United States and whites. The disparities reported by the researchers include among the 
myriad explanations for these disparities patient mistrust and physician bias:  
lack of awareness of stroke symptoms and signs and lack of knowledge about the 
need for urgent treatment and the causal role of risk factors…differences in 
attitudes, beliefs, and compliance among minorities compared with whites. 
Differences in socioeconomic status and insurance coverage, mistrust of the 
healthcare system, the relatively limited number of providers who are members of 
minority groups, and system limitations may contribute to disparities in access to 
or quality of care, which in turn might result in different rates of stroke morbidity 
and mortality… Although unmeasured factors may play a role in these delays, the 
presence of bias in the delivery of care cannot be excluded. [69].  
 
Another type of study, led by epidemiologists using some microsociological tools (e.g., 
conversation and interaction analysis) [15] sought to examine physician-patient communication 
in depth.  These studies analyzed differences in physicians’ interaction styles and behaviors with 
black and white patients, finding that many times, physicians’ conversations with black patients 
differed in content and quality from their conversations with white patients.  Specifically, 
physicians were more likely to lecture black patients and “adopt a narrowly biomedical 
communication pattern with African Americans, a pattern associated with low satisfaction 




level factors nor others inquiring into physician behaviors, attempt to answer exactly how 
“subconscious perceptions” or biases may be leading to the disparity
7
.  However, the existence of 
findings of disparate treatment reported both subjectively and objectively, bolsters the argument 
for additional research to pinpoint possible causal mechanisms. 
Systemic Lupus Erythematosus (SLE) and Health Disparities 
 
Between 1 and 2 million people in the United States live currently with some form of 
Lupus Erythematosus, an inflammatory autoimmune disease often called the “great imitator” 
because its symptoms so often resemble those of other common diseases. Although lupus can 
take many forms, including discoid (affecting only the skin) and  drug-induced, most people with 
lupus have Systemic Lupus Erythematosus (SLE), a form that can affect almost any organ 
system in the body
8
. Early symptoms of SLE include: fatigue; joint and muscle pain; skin rashes; 
unexplained fever; alopecia; chronic anemia; pleuritis; and pericarditis. More advanced 
symptoms can include: renal failure; seizure; stroke; psychosis; brain swelling; and cardiac arrest 
[71].  
SLE affects women disproportionately  (8 women:1 man) and is usually diagnosed during 
women’s child bearing years (ages 15 to 45), although infant SLE and geriatric SLE cases have 
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 Most often, SLE affects the joints, tendons and other connective tissue, skin, brain and nervous system, heart, 






also been reported [72]. The incidence and prevalence of Systemic Lupus Erythematosus in the 
US population is 1.6–7.6/100,000 population/year and 30 - 50/100,000 population, respectively. 
Among African American/black women in the US, SLE incidence is almost eight  times that of 
the general population  (8.1–11.4/100,000 population per year)
9
 [72]. 
Health disparities-focused epidemiologic research on SLE has revealed additionally that 
SLE is disproportionately prevalent not only among African American/ black women, but also 
among women of other minority groups in the U.S. including: Hispanic/Latina ethnicities, 
regardless of race; Chinese; Philippine; and American Indian women. In the same way, 
published studies of racial prevalence of SLE in the United Kingdom suggest that people of 
African descent (Caribbean and West African) may be at 3 to 5 times greater risk for developing 
SLE and for exhibiting more severe symptoms, despite the fact that SLE is rare in West Africa 
where these groups originate [73]. South Asians in the UK have 3 times the risk of having SLE 
than do whites [74]. Additional international studies demonstrate that “the prevalence rates for 
Hispanics and Asians [in Europe], while greater than those for most European populations, are 
generally less than rates for populations of West African ancestry[; and] in Hawaii, SLE is 4 
times more common among native Hawaiians and Asias compared with Caucasians” [75].  
In an attempt to uncover the causes for the observed racial/ethnic differences in SLE 
prevalence, biomedicine, aided by advances in technology, has focused its efforts on deciphering 
the genetic roots of the disease but thus far has revealed few results lending to translation into 
effective genetic therapies [76-81]. At the same time, social science inquiry into the disparities in 
SLE prevalence has grown. This research elaborates on the basic measures of socioeconomic 
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status/position (SES/SEP), place of residence, private versus public health care and migration, 
used in the 1964 SLE study that changed the profile of SLE from one of fair-skinned white 
women in suburban settings to urban, black and Puerto Rican women [82], and finds some 
evidence that factors other than or in addition to genetics may play a role in SLE severity for 
women of color in the U.S. These studies have found that groups of color are more likely to be 
diagnosed with lupus at earlier ages and later stages of the disease (i.e., they present with more 
symptoms at diagnosis); receive less effective treatment for their symptoms; report lower health 
related quality of life (HRQOL) and lower psychological well-being; and face higher and earlier 
morbidity and mortality than is the case among white lupus patients [83-88]. These consequences 
have also been found to be independent of educational attainment and family wealth [89, 90].  
The findings presented have seemingly prompted an uptick in race-specific recommendations for 
rheumatologists and other physicians treating patients with SLE [91, 92].  
All of the descriptive biomedical, social epidemiology and social science studies cited 
focus nearly exclusively on patient-level factors that influence health disparities among black 
women with SLE. The explanatory factors explored in these studies are: lack of compliance with 
drug regimens; inadequate or abnormal coping with illness; less frequent health care visits due to 
lack of private health insurance coverage; and low educational attainment [34, 89, 90]. There is, 
however, a paucity of research that adds to the understanding of physician-level factors that may 
contribute to race-based SLE disparities. [93, 94] [44].[94].  
Status in the Physician-Patient Encounter 
 
Commonly used to mean esteem or good repute, in much of social science literature 




one of three bases of social stratification. Among force and force threat (power), wealth, [and 
possibly friendship-love-affection], Goode identifies prestige as the social stratification concept 
worthy of “separate development” in order to facilitate an understanding of the processes of 
social control. He defines prestige as “the esteem, respect, or approval that is granted by an 
individual or a collectivity for performances or qualities they consider above 
average…[p]restige (negative or positive) may also be granted for qualities with which the 
individual is endowed at birth, such as nobility, membership in an ethnic group, or perhaps 
musical genius.” In his estimation, not only do social actors receive esteem for their own 
qualities or accomplishments, they are also praised for granting the “right kind of approval” to 
others. We learn from the response of those around us that we have reacted ‘correctly.’” 
At the same time as societies grant praise and esteem, they also remove it through 
dispraise and disapproval: 
The initial responses of low, high, or average respect for others’ qualities and 
performances are inner feelings or articulated decisions. Eventually, however, 
both the judges and the judged come to have at least some guesses or knowledge 
about each other’s rankings, for such evaluations are translated eventually into 
observable actions , even when the depreciated person  does not learn why. He 
may be left out of conversations, receive fewer social invitations, lose customers, 
be passed over instead of promoted, and so on. Thereby people not only learn in 
general how well they are respected or disapproved, approved or disesteemed; 
they even come to learn with some accuracy who harbors which judgments 
(though with less accuracy about pejorative evaluations). Because of these 
reciprocal processes, by which both those who rank and those who are ranked 
come to learn about each other’s evaluations, disapproval usually appears as the 
social phenomenon of dispraise.[95] 
 
Dispraise can be communicated through gesture, facial expression, verbally (as a serious 




effects. In mathematical fashion, Goode asserts the following hypotheses about dispraise. First, 
that the more an “ individual falls below the norm set by those in interaction with him or her, the 
greater the frequency of any performance below the norm and the greater the supposed bad 
effects of the inadequate performance” [95, 96]:  the more members of the group will experience 
dispraise; the more likely dispraise will be expressed directly (overtly);  the more likely that 
others will join in disapproval; and “the greater the chance that other sanctions or controls will be 
applied against the offender…[and;] the greater the likelihood that the criticism will contain 
moral overtones or be expressed in moralistic rhetoric; and that the critic will display anger”[95]. 
Another hypothesis recognizes that those of higher status are less likely than those of low status 
to receive overt criticism. Finally, Goode hypothesizes that the higher the critic’s rank, the more 
likely observers and the criticized herself, are to agree with the criticism. In sum, prestige 
(esteem) and its converse, disapproval, function to control and correct behavior, both of the 
criticized and of the group to whom the criticized belongs. In this social order this type of 
negative control is applied inequitably: the more powerful (socially superior group) being less 
likely to receive strong overt sanctions than the less powerful (socially inferior group) [95].  
Many times sanctions are based on stereotypes about the socially inferior group. Rubio 
and Washington underline that whites continue to hold negative views of blacks and other 
minorities. They report that 44% of whites surveyed in the General Social Survey in 1990, 
considered that blacks were lazy and over 50% indicated that blacks preferred to live on welfare. 
Fewer than 20% of whites endorsed positive stereotypes of blacks. Rubio and Washington 
conclude from this data that: “such high levels of negative stereotypes are likely to have 




policy. Research on stereotypes indicates that the endorsement of negative racial stereotypes 
leads to discrimination against minority groups”[97].  
Closely related to the concepts of prestige or status and stereotyping, is stigma. 
According to Link and Phelan, stigma exists when labeling of human differences, negative 
stereotyping, labeled persons are categorized into “us” and “them”; and when access to social, 
economic and political power allows for the construction of stereotypes, the separation of people 
in categories and “the full execution of disapproval, rejection, exclusion, and discrimination” 
[98]. Erving Goffman described three types of stigma: physical deformities; blemishes of 
individual character; and the tribal stigmas of race, nation and religion [99]. All of these types of 
stigma have the same effect. They are a “trait that can obtrude itself upon attention and turn 
those…he [the stigmatized] meets away from him, breaking the claim that his other attributes 
have on us” [99]. Not only do we recognize and shy away from the stigmatized, we actively 
reduce the life changes of the stigmatized person: “we construct a stigma-theory, an ideology to 
explain his inferiority and account for the danger he represents, sometimes rationalizing an 
animosity based on other differences, such as those of social class…we tend to impute a wide 
range on imperfections on the basis of the original one” [99].  
Using the Link and Phelan stigma classifications related above, Kwate argues that racism 
should be evaluated as a form of stigma on the basis of the lived experience of African 
Americans as a group whose skin pigmentation is labeled in contrast to “white” skin; whose 
“blackness” is linked to a set of undesirable characteristics; and whose experience of residential 
and social segregation constitutes a de facto demarcation of “us” and “them.”  She states that for 




necessarily logical or consistent and whose…role is to relegate [blacks] to ‘either/or’ roles that 
reinforce a limited and marginalized status [100]. These include:  the ascription of inferior 
intellects to black people that “in school settings…underlies peer perceptions of undeservedness, 
inequalities in educational placement, and attacks on affirmative action” [100];  the ongoing 
message that black people, especially black men, are dangerous and prone to criminality;  the 
perception of blacks as lazy and uninterested in work; the view that blacks, both men and 
women, are hypersexualized, leading to the vision of Black reproduction …as a form of 
degeneracy…[while] white childbearing is thought of as a personal joy that allows the nation to 
flourish” [100]; that black people, especially black women, are servants; that blacks are vectors 
of disease and contagion; that black people are rhythmically and athletically gifted
10
; that black 
people are primitive,  and are therefore driven by base instincts and are able to “withstand 
extremes of heat, physician labor, and pain
11
”. 
Kwate and Meyer argue that the application of these stereotypes in and of themselves can 
harm the health of African Americans: “stereotypes of African Americans fuel a moral economy 
that not only takes an intrapsychic toll on Black minds, but also subtly interweaves policies and 
practices that subordinate Black people” [102]. 
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 Recent studies prove the continued reliance of this stereotype in medicine, as African Americans are still less 
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Thus prestige, stigma, racism, stereotyping and discrimination converge to create a 
thorny relationship between physicians and patients. Physicians, in a place of authority and thus 
greater prestige have and are exhorted to gain the compliance of patients, perhaps members of a 
stigmatized racial or ethnic group to which all manner of negative stereotypes have been ascribed 
[103]. How do the physician and the patient tread these waters? 
Power and Social Interaction in the Medical Space 
 
The literature on social interactions in the medical encounter reviewed here is explicit in 
its implication of power as the main driver of action and/or inaction.  These works approach 
power in two ways—structural-functionalist and social constructionist. Mason explains these two 
camps in the following way in his review of the literature of the physician-patient interaction: 
[m]edicine, from the functionalist perspective, is viewed as a means of alleviating 
deviance, a benevolent way of restoring patients to normality, and thus 
maintaining social order in a consentualist society. In the eyes of political 
economists, medicine is largely an instrument of domination used by the ruling 
classes to maintain their powerful position…For the social 
constructionists…illness and disease are products of specific historical and 
political circumstances, with medical practices also responding to these 
circumstances. Some social constructionists recognize the need for a power 
imbalance to fulfil [sic] the expectations and needs of both doctors and patients, 
and therefore lean towards the functionalist perspective, while others conform 
more to the political economy perspective in seeing a struggle for power in the 
medical encounter with patients being controlled and oppressed by doctors. [104] 
 
The preeminent and ostensible founder of the structural-functionalist conception of health 
and illness is Talcott Parsons. His now much-critiqued “sick role” concept presents illness not 
only as a biological phenomenon, but also as a social role whose boundaries are dictated by 




the express purpose of exempting the sick person from her prescribed social duties for the 
duration of the illness and allowing her “the claim that he/she is irresponsible for the state of 
sickness” [106]. To perform the role successfully, the patient must additionally desire to get well, 
seek professional help in recovering from the illness and cooperate with the prescribed treatment. 
In Parson’s conception, the power differential between physician and patient is needed to absolve 
the patient of her responsibility for accomplishing her duties. To the functionalist perspective, 
power itself is construed as a “generalized social resource flowing through the political system, 
given by general consensus to those who have earned it through their contribution to society [and 
is] necessary to serve the interests of society as a whole [and] to the physicians’ successful 
accomplishment of his “healing function, and thus ultimately serving the best interests of the 
patient”[104].  
Though much of the biomedical and medical sociological literature on trust in the 
medical establishment offers a functionalist perspective on the importance of the physician-
patient interaction in improving compliance though active patient participation in the medical 
visit and physicians’ use of patient-centered communication techniques [107], they pay little 
attention to larger theoretical constructs of power and agency
12
. Power in the functionalist sense, 
therefore, is a necessary component to successful social interaction and the carrying out of 
important social tasks.   
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The social constructionists focus on power relations between patient and physician as 
“the property of institutions, groups, or individuals” that reflect traditional power structures [108-
111].  In illustration, the cultural anthropological/sociological perspective renders the physician-
patient interaction an “embodiment” of culture and the established moral order [35, 106, 112-
117]. In this social constructionist view, “social experience connects institutional structures and 
systems of collective meaning that together constitute the moral order which body-self 
processes….Thereby, the social world enters into cardiovascular, endocrine, and neurobiological 
processes so as to pattern responses. In turn, bodily and self processes project into social space, 
bringing affect and embodied meaning to bear upon social life” [117].   Farmer views this 
“embodiment” as a reflection of structural violence, “suffering [that is] ‘structured’ by 
historically given (and economically driven) processes and forces that conspire…to constrain 
agency” [113]. Social constructionists legitimize explanations for disease based on the lived 
experiences of the sufferer that are often at odds with biomedical findings and methods that 
purport objectivity [116].  
Swidler takes the analysis of social interaction and its manifestation in culture in a 
different direction—away from the power of individuals or groups and toward the power of 
culture itself. She analyzes the relationship between cultural influence and action not as mediated 
through values (Parsons), ideas (Weber) or interests (Marx) because these indicators are weak 
predictors of action, instead she offers a view of culture as “a ‘tool kit’ of symbols, stories, 
rituals, and world-views which people may use in varying configurations to solve different kinds 
of problems” [118]. The tool kit imagery serves to emphasize that the organizing functions of 




So, the first and most easily seen level of interaction and influence between the SLE 
patient and her physician in the medical encounter is the ability of the doctor to influence the 
patient’s behavior based on the legitimacy of her chosen profession and the prestige afforded her 
by society and by the patient. Her power also allows her to mete out praise and dispraise in a 
manner that may reflect her understanding of the physician’s role and the proper posture 
(deference) of the patient, her understanding of the social order (i.e., who is deserving of or 
compliant with treatment) or her ability to wield a “tool kit” better applied to the medical setting 
than can the patient in question.  On the patient’s side, communication with the physician may be 
thwarted because her tool kit may lack the instruments necessary to conduct collegial 
interactions with physicians steeped in an institutionalized medical and/or class/racial culture. In 
addition, it must be understood that the patient’s adherence, considering her lack of power and 
prestige is based both on her calculation of the costs and benefits of obedience as well as on her 
translation of the cross-cultural interaction with her physician that may include disapproval 
communicated through words or actions.  
Chapter Summary 
 
In sum, I have reviewed the literature on modern racism and stereotypes and tied both to 
poor health care and health outcomes for African Americans. I have also described how these 
racial stereotypes have historically been part of biomedical understandings of differences in 
disease morbidity and mortality among races and have summarized a time line of the medical 
sociological movement that has reframed the biomedical discussion in terms of social and 
environmental factors. I reviewed several biomedical studies that have adapted the health 




profess to hold strong racist or sexist beliefs, studies continue to find that blacks receive inferior 
treatment for life threatening illness. Additionally, I found that although many studies find that 
unconscious bias may play a role in unequal treatment, few have explored how these biases 
cause disparities.  I also looked specifically at the literature on patient-level factors and 
physician-level factors that have been said to cause or exacerbate race-based health disparities in 
the treatment of and medical outcomes for patients with Systemic Lupus Erythematosus (SLE).  
Finally, I explained the context of the physician-patient interaction and the power relations 
inherent in this relationship and concluded that the power imbalance and differences in cultural 
toolkits between physicians and their patients may be a source if the differing health outcomes 




CHAPTER 3: METHODS AND PROCEDURES 
Sample Recruitment 
 
 Between November 2011 and November 2012, data for the study were collected from 
study participants recruited both face-to-face and by mailed invitation. All data collection and 
recruitment materials were reviewed and approved by the Columbia University Medical Center 
Institutional Review Board (IRB).  First, face-to-face recruitment was carried out during the 
November 2011 American College of Rheumatology (ACR) Annual meeting in Chicago, IL. The 
sample consisted of 42 willing and qualified physicians (MDs and DOs practicing medicine in 
the United States) who were conference attendees asked to participate as they passed the study 
booth located in the meeting’s Exhibit Hall. Then in February of 2012, 3,124 letters of invitation 
to participate in the study were sent to active clinical members of the American College of 
Rheumatology
13




By July of 2012, 50 participants had completed the study online. In order to encourage 
additional response, an email invitation to participate in the study was sent to the coordinators of 
111 of the 112 recognized rheumatology specialty training programs in mainland United States 
(Puerto Rico was excluded). The list of fellowship programs was downloaded from the American 
Medical Association’s Fellowship and Residency Interactive Database (FREIDA).  According to 
AMA statistics, the average number of active fellows and residents in these programs in 2012 
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was 430, with about 3.8 residents/fellows per program, so the total number of potential 
rheumatology specialty program participants contacted was about 407
15
. After July 2012, 9 
additional respondents completed the study.  Thirteen envelopes from the original February 2012 
mailing were returned with incorrect addresses
16
 and four coordinator emails bounced back as 
either on leave or no longer in the coordinator position. The total number of study participants 
recruited by postal mail and email was 59 of the 3,518 contacted.  These 59 responses were 
combined with the 42 ACR respondents to form a sample of 101 participants
17
.  No monetary or 
non-monetary incentives for participation were offered.   
As described above, data collection was carried out both face-to-face and anonymously 
via internet. All respondents used computers to respond to questions on treatment 
recommendations, personal characteristics (physician demographics and patient race and affect) 
and explicit discriminatory beliefs.  Face-to-face  participants completed a paper-and-pencil 
version of a test of unconscious discriminatory beliefs called the Implicit Association Test (IAT), 
described in further detail below, while internet respondents were administered a similar 
computer-based measure called the Brief Implicit Association Test (BIAT). 
Procedures 
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 Thirteen envelopes were returned to sender, but email addresses were located for two of the recipients and an 




 Of the total 101 study participants, four participants were dropped from the analysis due to significant non-
response (answered only demographic questions); one duplicate responder’s second pass at the survey (confirmed 
by use of duplicate respondent number, IP address and time/date stamp) was deleted; and two non-physician 




For the face-to-face sample, the paper-format IAT preceded the survey and the explicit 
measures of bias were the final section of the survey (Appendix 2).  I will describe here the 
administration of the paper-format IAT and the BIAT that were analyzed for this study. The 
face-to-face sample responded to a paper-format version of the IAT using paper and pencil. One 
person was brought to a table inside the 8’x8’ booth and sat at the center of the table to do the 
timed paper-format IAT with me. I turned my back and gave the instructions over my shoulder to 
start and stop each section, two practice and two experiment. After the IAT was completed, the 
form was placed in a folder and the participant was led to one of two computers at each end of a 
6-foot table situated lengthwise along the side of the booth (Figures 1 and 2). The booth next to 
mine was empty, lending additional privacy to participants (Figure 3). Once seated at the 
computer, the participants chose a piece of paper containing the number of the vignette and the 
race of the patients the participants would be assigned from a bucket. The participant was then 
handed his or her patient vignette to read and instructed to begin the Survey monkey-based 
survey already loaded on the computer. When the booth was full, a third computer at the center 
of the table was used to administer the survey and no new participants began the study until the 
center of the table was again available. 
The internet-based participants (see Appendix 3 for website screen shots and links) 
responded to the BIAT online anonymously by downloading a temporary program provided by 
Millisecond.com.  Access to the study survey, housed on the Survey monkey website, and the 
BIAT was granted following direction to the study’s web page, 
http://www.armbristerdissertationsite.com where the participants first read the informed consent 










Figure 2. ACR Booth. Front View 
 





The study survey asked the physicians a series of 14 demographic questions to establish age 
group, gender, race and ethnicity, training, practice setting, medical specialization, duration in 
the current clinical position and to screen for physician status (DO or MD). Participants in the 
face-to-face study were then assigned randomly to one of six vignette scenarios, while those in 
the online study were randomized to one of four scenarios. After answering the demographic 
questions and reading the vignettes, participants were asked to recommend prescriptions, testing, 
follow up and specialist referral in closed-ended formats that allowed for additional open-ended 
explanation. Following the treatment recommendations section, the physician respondents were 
asked to indicate how available a series of common prescriptions and medical tests and 
procedures are for their patients. Participants then responded to a series of items evaluating the 
patient’s personal characteristics. Finally, the physicians were asked to identify the race of the 
patient they saw in the photo attached to the vignette. For the computer-based respondents, both 
the implicit (BIAT) and explicit (SDO, MRS and MCPR) discriminatory measures were 
administered after the survey was completed.  
The Vignette Experiment 
 
Vignettes are used in social science and medical research to elicit discussion of ethically 
sensitive issues and to observe decision-making. Vignettes have been found to be valid, cost-
effective measures of quality of care, decision making and clinical competence [119, 120] after 
years of doubt about how accurately they measure actual behavior [121]. Vignettes usually 
employ a factorial design in which several situations are constructed and relevant factors of the 
characters (e.g., race, gender) are varied. Systematic difference in decision-making is an 




The present study employed a 2x2 (patient race by symptom severity) factorial design. In the 
first vignette a 22-year-old woman presented with a mild, even ambiguous, case of lupus 
nephritis, along with three additional mild symptoms common to patients with SLE (dermatitis, 
respiratory infection and pleurisy (inflammation in the lining around the lungs) (Figure 4)) and in 
the second a 22-year old woman presented with more serious symptoms of progressing lupus 
nephritis
18
 (Figure 5) and no additional symptomology. In the face-to-face data collection, three 
photos, one of a dark brown skinned/black woman, another of a brown skinned and the last of a 
light skinned/white woman (Figures 6, 7 and 9), were matched randomly with each vignette 
presented to the physicians.  For the online data collection, two photos, one of a dark brown 
skinned/black woman and the other of a light skinned/white woman (Figures 6 and 8), were 
matched randomly with each vignette. For the purposes of description in the rest of this thesis, 
the dark brown skinned woman will be referred to as black and the light skinned woman will be 
referred to as white.  The brown skinned woman will continue to be referred to as brown.  All 
photos were of young women of approximately 22 years of age. Thus, for the face-to-face data 
collection there were six conditions: black female patient with acute or ambiguous symptoms; 
black female patient with severe symptoms; brown female patient with acute or ambiguous 
symptoms; brown female patient with severe symptoms; white female patient with acute or 
ambiguous symptoms; and white female patient with severe symptoms.  For the online data 
collection, there were only four conditions: black female patient with acute or ambiguous 
symptoms; black female patient with severe symptoms; white female patient with acute or 
ambiguous symptoms; and white female patient with severe symptoms.  
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 Glomerulonephritis is a complication of SLE that occurs in about 30% of people with SLE.  Renal failure caused 





Development/Creation of the Vignettes 
The vignettes were sent via email and reviewed by two practicing rheumatologists
19
 and were 
again validated during the ACR face-to-face data collection in which participants were invited to 
provide feedback on the study elements.   
Patient race was manipulated via photographs. Models for the black and brown patient 
photos were recruited at a conference of Afro-descendant youth from Latin America and the 
Caribbean held in Costa Rica in September of 2011. The final black patient model for the online 
data collection was decided on because there was no ambiguity about her racial classification 
among 5 evaluators, as was the case with the other two models recruited at the conference. There 
was also no ambiguity about her race among the 16 participants who received a vignette with this 
model at the ACR meetings, as 100% classified her as black or African American.   
The model for the white photo was not as easy to find because I live in Latin America 
where most non-black, non-Indigenous people are mestizo, that is a mix of Indigenous, African 
and European that it seems to U.S. physicians does not seem to perceive as white. Figure 8 
shows the original photo used for the white patient at the American College of Rheumatology 
meetings. A new photo for the white patient (Figure 9) was used for the online recruitment. The 
model is a friend of the researcher who was conducting research in Colombia for graduate work 
in 2011 and the photo was taken with a different camera than were the other two photos so 
efforts were made to blur the black patient photo such that the quality would differ less from the 
photo in Figure 9 than it appears below. 
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 The vignettes were reviewed by Dr. Linda Shookster and Dr. Anka Askanase. An additional invitation to evaluate 




The “Brown” Factor 
My original dissertation study was envisioned as a comparison between physicians’ 
treatment decisions in Brazil and the United States in which I would observe differences in 
treatment recommendations made for black (preta), brown (parda) and white (branca) patients.  
However, in the four months between data collections, I received word from the Brazilian Health 
Ministry that I would have to enlist a Brazilian institution in order to carry out my research in 
Brazil.  Previous to this, the director of the Brazilian Rheumatology Association had refused my 
request to collect data at their annual meeting in Vitoria, Espritu Santo, Brazil, scheduled for 
December of 2011.  These occurrences forced my decision to eliminate Brazil from the research 
and at the same time eliminate the brown female patient from the options to be presented to 
online study participants
20
 because in the US context, the brown patient would have little to no 
significance, a fact that was reflected in my original hypotheses
21
.  I therefore decided to 
eliminate the brown patient photo for the online data collection. 
The decision to eliminate the brown patient from the online data collection and the need 
to change the photo of the white patient for online collection, posed dilemmas for data analysis.  
First, I felt I needed to reclassify the responses to the ACR data collection for which the 
participant was assigned to the brown patient to fit these within the new black-white binary. 
Data from the respondents at the ACR meetings showed that 66% of the 12 participants who 
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 The study hypothesized that despite that the Brazilian racial classification system that separates black and mixed 
race (black and another race), Brazilian physicians would provide similar less efficacious treatment for both blacks 
and mixed-race people. 
 
21
 The original study’s first hypothesis was: “…that physicians in the United States will conform to the prevailing 
“one drop rule” in the assignment of race, while Brazilian physicians will choose a range of racial classifications that 





were randomly assigned to the brown patient (Figure 7), classified her race as black, 1 
participant classified her as American Indian and another participant classified her as “other 
(human, possibly multiracial, not sure)”. Based on the classification of American Indian and 
multiracial as non-white, I decided to group this 33% of non-white responses for the brown 
patient as black to facilitate analysis across data collections.  In the case of the original white 
patient whose photo was received more often as representing a non-white person, I decided to 
classify her based on the physicians’ racial classifications; she was “white” (5 responses) except 
in cases in which the physicians in the face-to-face study classified her as Hispanic (3 
responses), black/African American (3 responses) or unknown (2 responses). These non-white 
classifications of the original white patient photo (Figure 8) were included in the data analysis 
as “black” to facilitate comparison with the binary racial categories included in the online data 
collection.   The one instance in which the experimental white patient photo (Figure 9) was 







Distribution of Participants Among Experimental Conditions 
 












N (94) 31 5 3 14 13 7 10 11 n/a
N Face-to-Face/ACR 
(41)
12 5 3 n/a 4 7 10 n/a n/a
N Online (53) 19 n/a n/a 14 9 n/a n/a 11 n/a
% Female (N=38) 32% 60% 66% 50% 46% 43% 20% 45%
% Non White (N=25) 30% 20% 67% 21% 15% 57% 10% 27%
% White (N=68) 70% 80% 33% 79% 85% 43% 90% 83%



















Explicit Bias Measures 



















% Black (N=55) 100% 40% 33% 7% 92% 86% 20% 0%
% White (N=26) 0% 0% 33% 86% 0% 0% 40% 82%
% Other (N=13) 0% 60% 33% 7% 8% 14% 40% 18%




2This  compos ite measure sums the responses  to the SDO and MRS sca les .  Because the SDO sca le presented in the s tudy has  more 
i tems and a  larger range of responses , means  are influenced more by scores  on the SDO sca le.





1 Percentages  show the dis tribution of participants  to the experimental  conditions  (column percentages).
 
 
Table 1 shows the distribution of participants to experimental conditions.  The first three 
rows show the overall distribution of participants irrespective of participant characteristics.  The 
remaining rows show the distribution to experimental conditions by subgroups of participants.   
Row 1 shows that the 94 participants were slightly more likely to be assigned to a black patient 
(n=44) than to be assigned to white patients (n=38) and to be assigned to an ambiguous or acute 




experimental conditions by participant gender, race, age and explicit bias. Implicit bias is not 
included in the table because the study employed two methods to measure implicit bias—the 
paper-format Implicit Association Test and an online Brief Implicit Association Test (BIAT) —
whose results cannot be combined because of differences in scoring, though they are 
comparable.  Finally, Table 1 shows participants’ assignment of patient race into three 
categories (black, white and Other (includes American Indian, Hispanic/Latino, unknown and 
biracial)) by vignette picture color and symptom.   
To assess whether there was significant imbalance in the assignment of participants with 
different characteristics to experimental conditions, the table reports p-values from chi-square 
tests for gender and race and from analyses of variance for participant age, a combined explicit 
bias measure that includes the results of both the social dominance hierarchy scale and the 
modern racism scale and the racial identification that participants selected for their patients and 
patient assigned race.  The results show no significant imbalance by demographic characteristics. 
The significant association between experimental condition (acute/ambiguous symptoms versus 
severe symptoms) and explicit bias measures (p < 0.019) indicates that the distribution to 
experimental conditions was imbalanced in terms of preexisting level of explicit bias or that 
reported explicit bias was influenced by vignette condition.  Participants who received the severe 
symptom vignette reported higher average explicit bias scores (mean = 3.57) than participants 
who received the acute/ambiguous symptom vignette (mean = 3.39); the difference was 
statistically significant.  Perceived race of patient and vignette picture color were significantly 
associated (p < 0.001).  This indicates agreement between race as presented and perceived rather 




Table 2. Re-assigned Patient Race Groups1 
Black White Black White
N (94) 37 15 22 20 n/a
N Face-to-face/ACR 
(41)
18 2 13 8 n/a
N Online (53) 19 13 9 12 n/a
% Female (N=38) 35% 60% 41% 35%
% Non White (N=25) 25% 40% 32% 15%
% White (N=68) 75% 60% 68% 85%























% Black (N=55) 89% 13% 91% 0%
% White (N=26) 0% 74% 0% 70%
% Other (N=13) 11% 13% 9% 30%
2This  compos ite measure sums the responses  to the SDO and MRS sca les .  
Because the SDO sca le presented in the s tudy has  more i tems and a  larger range 
of responses , means  are influenced more by scores  on the SDO sca le.
Participant Race
0.378
Perceived Race of Patients 
0.001*
*alpha = .05
1 Percentages  show the dis tribution of participants  to the experimental  conditions  
(column percentages).






 In response to the problem presented by the “brown” photo in the face-to-face 
administration, I reassigned patients to one of two races, black or white, adding all “patients” 
identified by participants as black or Other (American Indian, unknown, biracial and 
Hispanic/Latino) as “black” and all other “patients” as white.  The previous table showed the 
actual assignment of patient race by study participants; Table 2 shows the distribution of patient 




result of this adjustment was an increase in the number of black patients from 44 before the 
adjustment to 59 afterward.  The 15 additional black patients were added in the following 
manner: 12 brown photos that were classified as black, American Indian or Other 
(unknown/biracial) and 3 white photos from the ACR face-to-face data collection were classified 
as black. An additional white photo from the online data collection that had been classified as 
black was not added to the black patient data, but rather remained with white patient photos for 
the data analysis because I established that the online photo was more clearly white than was the 
photo presented during the ACR data collection.  Therefore the number of white patient photos 
was reduced by three from 38 to 35.  
 Row 1 of Table 2 shows that, after reassignment, the 94 participants were more likely to 
be assigned to a black patient (n=59 or 63%) and were slightly more likely to have been 
assigned to ambiguous or acute symptom vignettes (n=52 or 55%).  Next, Table 2 shows the 
distribution of participants to reassigned race/symptom groups by participant gender, race, age 
and explicit racial bias.  To assess whether there was significant imbalance in the assignment of 
participants with different characteristics to reassigned conditions, the table reports p-values 
from chi-square tests for gender and race and from analyses of variance for age, the explicit bias 
measure and patient racial assignment.  The only significant association that remained after the 
racial re-assignment of the experimental conditions was for perceived patient race (p<0.001).  
As in Table 1, this indicates not an imbalance in vignette assignment but agreement between 
assigned and perceived race.  The problems of construct validity raised by my decisions about 




Figure 4. Acute/Ambiguous Lupus Nephritis Vignette 
   
 
 
Julia, a full-time employed 22-year old, presents for a routine examination and for tapering of her corticosteroid 
dose of 20 mgs per day.  Her disease has been mildly active over the past 3 years with a few episodes of joint 
swelling and pain and one episode of pleurisy.  She currently reports improvement in her ability to keep to her 
work schedule but has been experiencing palpitations and insomnia that she attributes to the corticosteroids.   She 
also requests a topical cream for treatment of an itchy rash on the nape of her neck.  On examination, the rash is 
irritated but not ulcerated.  The patient also reports having visited the hospital since her last office appointment 
because of a lower respiratory tract infection that the Emergency Room physicians also attributed to corticosteroid 
use.   She hopes to reduce her prednisone dose so that additional side-effects will not cause her to have to take 
time off from work.  Range of movement testing is normal and she shows few signs of joint inflammation. Blood 
tests show elevated creatinine (0.8 mg/dL) and lowered complements (C3 = 82 [ref. range. 83 – 174 mg/dL] and C4 
= 12 [ref. range 15 – 47 mg/dL]).   
 
 
Figure 5. Severe Lupus Nephritis Vignette 
Julia, a full-time employed 22-year-old, is suffering from stage 4 edema of the lower extremities.  She reports that 
the swelling began about 2 weeks prior and worsens as the day wears on, but reports no pain or reduction in urine 
output.  She claims that she urinates excessively in the early morning, thus reducing the swelling. The cycle begins 
again during the course of the day.  The patient has scheduled the appointment because she is concerned that the 
swelling is interfering with her ability to work.  She is also experiencing mild fatigue.  Her disease has been 
quiescent for about 3 years, but she has a history of moderate arthritis treated with oral and intravenous steroids 
and rashes treated topically.  She is not currently taking any medications. Range of movement testing is normal 
and she shows no signs of joint inflammation. Blood tests show elevated creatinine (1.8 mg/dL) and lowered 
complements (C3 = 80 [ref. range. 83 – 174 mg/dL] and C4 = 6 [ref. range 15 – 47 mg/dL]).  The patient is hoping to 







Figure 6. Black patient photo (Face-to-face and Online data collections) 
 
 





Figure 8. White Patient Photo (Face-to-face data collection) 
 
 








Implicit and Self-Reported or Explicit Bias 
 
The Implicit Association Test (IAT), introduced by Greenwald et al. [122], and priming 
studies are both sophisticated measures of affect toward blacks and whites that aim to uncover 
subconscious assumptions about race. These tests are characterized by their requirement for 
rapid response, thus increasing the likelihood that they measure automatic rather than controlled 
responses [123]. Implicit Bias
22
 was measured using both a paper-format Implicit Association 
Test (IAT) and the Brief Implicit Association Test (BIAT) used increasingly to measure 
unconscious bias due to its ease of administration and low cost [124]. The paper-format IAT 
asked respondents to rate names, stereotypically US black names (e.g., Lashelle, Rashaun, 
Malik) and stereotypically white names (e.g., Paul, Mallory, Rachel)
 23
, and a set of pleasant 
(e.g., terrific, joy)  and unpleasant words (e.g., evil, poison) (Figures 13 and 14). Respondents 
were given 20 seconds in which to fill in the bubbles next to congruous pairings (white names-
pleasant words) (Figure 13) then another 20 seconds in which to fill in bubbles next to discordant 
pairings (black names-pleasant words) (Figure 14). The response rate for the paper-format IAT 
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 Dr. Lemm sent the paper-and-pencil IAT to me on October 31, 2011.  The following names were deleted from the 
paper-format IAT before administration: Lionel (black name), Amber (white name) and Justin (white name).  Lionel 
was removed because the name is dated and is currently uncommon among African Americans.  Amber was 
eliminated because it has been classified as a crossover name, a name that whites and blacks are equally as likely to 
give to their children 125. Levitt, S.D. and S.J. Dubner, A Roshanda by Any Other Name, in Slate Online. 2005.  
Finally, Justin was eliminated because of the close association with the popular singer celebrities, Justin Bieber and 
Justin Timberlake.  Though these singers are white, there existed the possibility that assessment of the celebrity 
would trump assessment of the name.   The remaining names: Tanisha, Lashelle, Jamal, Rashaun, and Sharise were 






was 95% as all but two respondents’ paper-format IAT scores were analyzed
24
 resulting in an N 
of 39. The paper-format IAT measures the number of correct and incorrect responses to each 
pairing in order to calculate the IAT score.  The paper-format IAT was scored using the product: 
square root of difference algorithm that yields both negative and positive scores. The equation 
for the product: square root of differences is:   )  where X is the greater of the 
congruent pairing (side one of the paper-format IAT) and the incongruent pairing (side two of 
the paper-format IAT) and Y is the smaller of the congruent pairing and the incongruent pairing. 
Error rates for the paper-format IAT did not exceed 25%.  
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Figure 10. Paper-format IAT, Congruent Pairing 
Black  White  Black  White 
Unpleasant  Pleasant  Unpleasant  Pleasant 
       
 Tanisha    Sharise  
 hatred    vomit  
 Paul    Lashelle  
 good    terrific  
 Rachel    Mallory  
 love    hatred  
 Lashelle    Malik  
 poison    love  
 Jamal    Brandon  
 terrific    bad  
 Marty    Tanisha  
 hatred    good  
 Rashaun    Rachel  
 joy    joy  
 Malik    Rashaun  
 evil    evil  
 Brandon    Melanie  
 happy    happy  
 Melanie    Paul  











Figure 11. Paper-format IAT, Incongruous Pairing 
 
Black  White  Black  White 
Pleasant  Unpleasant  Pleasant  Unpleasant 




   Rachel  
 love    poison  
 Mallory    Paul  
 evil    good  
 Malik    Jamal  
 terrific    evil  
 Rashaun    Brandon  
 poison    love  
 Melanie    Rashaun  
 vomit    hatred  
 Rachel    Melanie  
 joy    joy  
 Lashelle    Malik  
 hatred    vomit  
 Brandon    Sharise  
 bad    happy  
 Marty    Paul  
 good    hatred  
 Tanisha    Lashelle  
 happy    bad  
   
 
The BIAT is a computer-based program that requires the participant to associate a series 
of positive and negative words with one of two target groups (black or white faces). Keystroke 




white faces) versus reaction times to incompatible blocks (e.g., pairing of positive words with 
black faces) is referred to as the IAT effect. A large IAT effect is indicative of negative affect 
toward the target group represented in the incompatible block (in this case, black faces) [126]. I 
programmed the BIAT test to measure bias toward light female versus dark female faces and 
eliminated male faces to isolate color/race bias from gender bias.  
Computer-based respondents completed the Brief Implicit Association Test (BIAT) 
consisting of five trial blocks of black and white faces (Figures 15 and 16) paired with good 
(e.g., wonderful, best) and bad (e.g., terrible, awful) words. Participants were scored based on the 
difference in lag time between responses in which white faces are paired with positive words and 
when black faces are paired with negative words. Scores for the BIAT were computed 
automatically by the Inquisit program that relied on a pre-programmed SPSS script and are 
reported as D scores, the product of mean latency response to the trial blocks. D scores can range 
from -2, bias toward blacks, to +2, bias toward whites. In order to access the BIAT, online 
respondents had to download a temporary application from the Millisecond.com website, the 




Figure 12. BIAT Black face example 
 
Figure 13. BIAT White face example 
 
   Missing data analysis reveals non-respondents in the computer-based group more likely to be 
foreign born (60% of foreign born respondents), non-white (53.8% of non-white respondents), 
female (44% of female respondents), hospital-based (43.3% of hospital-based respondents) and 
treating 30% or fewer SLE patients (42% of respondents treating 30% or fewer SLE patients).  
Several factors may have influenced non-response, including technical difficulties encountered 
with the Millisecond software and the incompatibility of the software with non-Windows-based 
platforms.  
The literature establishes that the paper-format IAT and the computer IATs “are strongly 
correlated and they may be assessing the same underlying construct. At the same time, the data 
suggest that the paper-format IAT is not quite as effective at eliciting strong mean effects as the 
computer-format IAT”[127].  
Explicit or Self-Reported Bias was measured using the results of responses to items from 
three surveys—two items from the Modern Racism Scale; four items from the Social Dominance 
Orientation Scale; and four items from the Motivation to Control Prejudice Scale (Appendix 2). 




although the intent of the survey may be masked using filler items. In the interest of making the 
instrument as short as possible, I did not add filler questions to the explicit bias measures.  I did, 
however, leave these measures for the end of the experiment in an attempt to avoid any priming 
that they might elicit in the participants.  
The Social Dominance Orientation Scale (SDO) [128] was created to assess respondents’ 
desire to maintain and justify social institutions and practices that either enhance or attenuate 
group hierarchy. The 6-item instrument uses a 7-point Likert scale (strongly agree to strongly 
disagree) to describe an arbitrary set-based hierarchy. In complement to age and gender-based 
hierarchies, arbitrary-set based hierarchy may include race, class, sexual orientation, caste, 
ethnicity and/or religious affiliation. The SDO score is an average of the responses to each scale 
item and higher SDO scores indicate higher social dominance orientation. The literature supports 
the assertion that the SDO is internally reliable with regard to inter-ethnic ideologies and that the 
reliability of SDO correlating with ideologies that maintain and legitimize social inequality is 
greater for men over women and for higher-status groups over lower status groups. Some suggest 
that SDO is more strongly predictive of racism and hostile forms of sexism than are other 
measures of dominance and inter-group attitudes [129]. There is evidence of both validity and 
reliability of the scale (Chronbach’s α = 0.83) for the measurement of discriminatory beliefs 
[128]. 
McCaunahay’s Modern Racism Scale (MRS) [21] is the most widely used (both in the 
U.S. and abroad) measure of “modern racism.”  Designed in the wake of a mayoral election in 
which a popular black candidate lost to a less-experienced white candidate, the 6-item scale 




voting behavior when a black candidate is involved and continues to be employed as a measure 
of race-based discriminatory affect. The Modern Racism Scale was envisioned as a less reactive 
way to elicit anti-black sentiment in white respondents than was its precursor, now called the Old 
Fashioned Racism scale, whose items were painfully politically incorrect after 1965 and thus 
became easy targets of social desirability bias and refusal to respond to the items, limiting the 
reliability and validity of the scale. For example, Old Fashioned Racism scales often referred to 
“beliefs about black intelligence, ambition, honesty and other stereotyped characteristics, as well 
as support for segregation and for open discrimination” [21]. Modern Racism on the other hand: 
is intended to measure a dimension of the cognitive component of racial 
attitudes…The principal tenets of modern racism are these: (1) Discrimination is a 
thing of the past because blacks now have the freedom to compete in the 
marketplace and to enjoy those things they can afford. (2) Blacks are pushing too 
hard, too fast and into places where they are not wanted. (3) These tactics and 
demands are unfair. (4) Therefore, recent gains are undeserved and the prestige 
granting institutions of society are giving blacks more attention that the 
concomitant status than they deserve. Two other tenets are added to this 
psychological syllogism: Racism is bad and the other beliefs do not constitute 
racism because these beliefs are empirical facts. [21] 
 
There is evidence that the MRS is reliable and valid for the measurement of anti-black 
sentiment (Chronbach’s α = 0.82) [130]. Scores across MRS items are averaged to a resulting 
modern racism score. High scores on the MRS are an indication of high levels of modern racism.  
The Motivation to Control Prejudiced Reactions scale (MCPR) [131] is a 17-item instrument 
summed across items to produce a motivation to control prejudice score. The Scale was created 
to address the seeming reactivity of the Modern Racism score observed when whites who 
completed the MRS in the presence of a black experimenter responded differently to items than 




that the expression of explicit racist beliefs, as required by the MRS, is culturally inappropriate 
in the presence of blacks, even if the respondent agrees with the statements presented.  The 
resulting theoretical models posited that the control of automatic racist beliefs lie at the core of 
racism affect. Those whites with automatic negative reactions to blacks but low prejudice scores 
are more motivated to control immediate responses to blacks because of a) distaste for behaving 
in a prejudiced manner; and/or b) a desire to appear non-prejudiced to others. Whites with 
automatic negative responses to blacks, but with high prejudice scores are therefore less 
motivated to control their reactions. There is evidence that the MCPR scale is both valid and 
reliable (Cronbach’s α = .81) for use in the measurement of the control of racist reactions when 
used with another measure of discriminatory affect, such as the MRS. The MCPR is the average 
of responses to each scale item. Higher MCPR scores indicate higher motivation to control 
prejudiced reactions. 
The study applied all measures of implicit and explicit bias to all participants, regardless of 
their race.  The Project Implicit website clarifies that:  
For White respondents, the automatic White preference may in some sense be an ingroup 
preference. However, the automatic White preference is more than that -- it is observed 
with similar strength among Asian Americans, for whom neither Black nor White is an 
ingroup. In this sense, the IAT may reflect an attitude that is learned through experience 
in a culture that does not regard Black Americans highly. Moreover, if the IAT result 
represented an ingroup preference exclusively, then Black Americans should show for 
their group the same level of automatic preference. We know that that is not the case. 
50% of Black Americans show automatic Black preference, but the remaining half show 
an automatic White preference. We conclude from such data that the IAT preference is 
some combination of an automatic preference for one’s own, moderated by what one’s 





Similarly, the analysis of aversive racism to be included in the study will include all participants, 
white and non-white, because Gaertner and Dovidio clearly underline the importance of implicit 
or unconscious bias as a central influence on aversive racist behavior [25]. 
Treatment Recommendations 
 
Treatment Recommendations for patients with SLE and possible lupus nephritis were 
divided into four categories: prescription; testing; follow-up; and referral. The items in the 
prescription recommendation and testing recommendation questions on the survey were 
presented in no particular order of importance. The order of efficacy was verified both by the 
literature [91] and in consultation with the rheumatologist member of the dissertation 
committee
25
. In the case of prescription, two variables, prescription potency and prescription 
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 Prescription potency (prescription potency) is a measure of the pharmacological strength 
and effectiveness of prescriptions recommended
26
.   The item was scored using the following 
scale, where higher scores indicate increasing potency: 1. no change in medication type or 
dosage; 2. non steroidal anti inflammatory drugs, NSAIDs (e.g., Naproxen); 3. 
hydroxychloroquinine; 4. oral immunosuppressives (e.g., micophenolate mofetil; methotrexate); 
5. oral corticosteroids; 6. intravenous corticosteroids; and 7. intravenous cytotoxic agents (e.g., 
cyclophosphamide, rituximab) [91]. 
Prescription potency with steroid combinations (prescription potency combination) is 
another measure of the pharmacological strength and effectiveness of prescriptions 
recommended that allowed for the interaction of corticosteroids and other medications.   The 
scale was scored using the following system, where higher scores indicate increasing potency: 1. 
no change in medication type or dosage; 2. non steroidal anti inflammatory drugs, NSAIDs (e.g., 
Naproxen); 3. hydroxychloroquinine; 4. oral immunosuppressives alone (e.g., micophenolate 
mofetil; methotrexate); 5. oral corticosteroids alone; 6. oral immunosuppressives + 
corticosteroids; 7. intravenous corticosteroids alone; 8. intravenous cytotoxic agents alone (e.g., 
cyclophosphamide, rituximab); 9. intravenous cytotoxic agents + corticosteroids. The two 
prescription variables, though similar, have an important distinction. The first variable includes 
oral corticosteroids only as a stand-alone category, while the second prescription variable 
includes steroids both as a stand-alone and in combination with other medications.  The inclusion 
of the steroid combination with immunosupressives and cytotoxic agents speaks to strength of 
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the physician’s goal of treating both short-term and long term symptoms.  The second category 
scores the combination of steroid treatment with immunosupressives and cytotoxic agents as 
“better” than the stand alone prescriptions.  
For testing three variables were created: invasive testing, testing requiring increased 
patient participation and the treatment national standard for renal biopsy. Recommendation for 
invasive testing (invasive testing) is a measure of physicians’ assessment of the need for 
increasingly complicated testing that may be viewed by the patient as invasive or that many 
cause inconvenience or complications for said patient. The item is scored using the following 
scale: 1. no testing; 2. cardiac stress testing; 3. urinalysis; 4. magnetic resonance imaging (MRI); 
and 5. renal biopsy. Higher scores indicate more invasive and clinically “better” treatment.  
Follow-up visit (follow-up visit) is a dichotomous variable that measures physicians’ 
recommendation for time to follow-up. The recommended follow up for possible organ 
complications is “3-6 month intervals…patients with… active disease will need more frequent 
follow-up…Patients beginning immunosuppressive medication will also require more frequent 
follow-up” [91]. A difference in time ranges between the face-to face data collection and the 
computer-based collection rendered the 1 month or less division as the most feasible within the 
guidelines laid out by the ACR, so the item compares the one month recommendation with all 
other recommendations. The item is scored: 1. 1 month or less; and 2. other response.  Shorter 
follow-up is considered the preferred treatment. 
 Specialist referral (specialist referral) is a dichotomous variable that measures whether 
or not the physician recommended referral to a(nother) specialist physician. The referral options 




infectious disease specialist; and 7. other specialist/write-in. The item is less a measure of proper 
treatment than a measure of willingness/ ability to collaborate on diagnosis. For this reason, the 
variable was transformed to the dichotomous: 1. no referral and 2. referral. 
There are several measures of treatment recommendations, some of which may support 
my hypotheses and others of which may not.  For this reason, it is important to indicate a priori 
which should be considered the most central treatment recommendations.  As a result, in the 
analysis I have prioritized responses to the categories prescription and testing recommendations, 
as the literature is clear that these two decisions are the cornerstone of medical interventions in 
cases of possible lupus nephritis (LN) [91, 92]. Therefore, findings in these two areas, 
prescription and testing, will serve to validate the hypotheses to be presented later in the chapter.  
Positive findings in the other four treatment recommendation areas will be highlighted, but will 
not constitute proof of having fulfilled the assumptions of the hypotheses.  
Personal Characteristics 
 
Patient personal characteristics were measured using physicians’ responses to a series of 
questions on patient affect and competence based on the list of patient characteristics evaluated 
by physicians in the Schulman et. al. study [61]. In the first part of the patient characteristics 
section, the characteristics were presented in pairs with the extreme negative of a characteristic 
juxtaposed with its extreme positive (e.g., hostile-friendly). The items were assessed using a 7-
point scale ranging from the extreme negative characteristic to the extreme positive 
characteristic. In the second part of the section, the physician respondents assessed the patient’s 




whether the patient would benefit from invasive procedures. The latter two sections were rated 
on a 5-point scale ranging from (1) very unlikely to (5) very likely (Figures 15 and 16).   
 
Figure 14. Patient Characteristics Assessment, 7-point Likert Scale 
Hostile (-3) (-2) (-1) 0 (+1) (+2) Friendly (+3)
Unintelligent (-3) (-2) (-1) 0 (+1) (+2) Intelligent (+3)
Lacking self-control (-3) (-2) (-1) 0 (+1) (+2) Self-controlled (+3)
Ignorant (-3) (-2) (-1) 0 (+1) (+2) Knowledgeable (+3)
Poor communicator (-3) (-2) (-1) 0 (+1) (+2) Good communicator(+3)
Dependant (-3) (-2) (-1) 0 (+1) (+2) Independant (+3)
Sad (-3) (-2) (-1) 0 (+1) (+2) Happy (+3)
Negative Affect (-3) (-2) (-1) 0 (+1) (+2) Positive Affect (+3)
Worried (-3) (-2) (-1) 0 (+1) (+2) Indifferent (+3)
Low socioeconomic      
Status (-3) (-2) (-1) 0 (+1) (+2)
High Socioeconomic 
Status (+3)
I consider this patient to be:
 
Figure 15. Patient Characteristics Assessment, 5-point Likert Scale 
very unlikely (1) 2 3 4 very likely (5)
Likely to over-report symptoms
Likely to miss appointments
Likely to participate
Likely to complain to higher authorities 
about treatment
Likely to comply with treatment
Likely to benefit from an invasive 
procedure(s)*
* For this item, the answer choices were: "much less than the average patient (1) to "more than the average patient" (5).




Physician Characteristics included: race (white or other); gender (female or male); age (ranges 
from 20-29 through 60 +); SLE patient case load (less than or greater than 30%); practice setting 
(private or public); and duration in the physician’s current clinical position (range from less than 




severe) was indicated by the vignette to which the study participant was randomized.   Each 
vignette was assigned a letter, indicating whether the patient symptoms were acute or ambiguous 
or severe. Similarly, exposure to one of the four vignettes (six in the case of the face-to-face 
sample) was an indicator of patient race, as each vignette was assigned a number indicating 
whether the patient was black or white.     
Patient Physical Attractiveness 
Patient physical attractiveness was divided in to four scores. As was indicated by the results of a 
survey of 63 independent evaluators (62% male)
27
, the black patient in the photo was more 
attractive than the white patient, but the degrees of difference in attractiveness varied by 
respondent race. So for the attractiveness variable, black patients assessed by white physicians 
received an attractiveness score of 6.63, the mean score given by white panel members who 
received the black photo. Black patients seen by physicians of color were scored 7.64, the mean 
attractiveness score for non-white respondents to the attractiveness survey. White patients 
assessed by white physicians received an attractiveness score of 5.32, the average score given to 
the white patient photo by white members of the judging panel. And white patients seen by non-
white physicians received a score of 4.71, the average attractiveness score given to the white 
patient by the non-white panel members. Patient attractiveness will therefore be treated as an 
independent variable that acts as a possible confounder to the possible relationship between 
patient race and the study’s dependent variables. 
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 Statistical Package for the Social Sciences versions 20.0 and 21.0 were used to analyze 
collected quantitative data.  Qualitative data (responses to open-ended questions) were analyzed 
using N*vivo 10 qualitative data analysis software. As the majority of hypotheses posed in this 
study involve categorical independent variables and continuous dependent variables,  ANOVA 
was the main test of statistical difference employed to assessed significant difference, though 
when both independent and dependent variables were dichotomous (e.g., patient race and follow-
up visit), cross-tabulations with chi-square statistics  were also employed. In addition, Cohen’s d 
effect size estimates were calculated for the Brief Implicit Association Test (BIAT) D scores. 
The effect size convention has been defined by the BIAT program as:  (less than .15), little to no 
bias; slight bias (0.15); moderate bias (0.35); and strong bias (0.65).  The program classified 




 The above described study elements were designed to answer the following hypotheses:  
Hypothesis 1: Physicians will make less efficacious treatment and follow-up 
recommendations for black patients when compared with white patients. These disparities in 
treatment decisions will be greatest when patients present with acute or ambiguous 
symptoms, rather than as severe cases. While the former half of the hypothesis reflects what 
is now referred to as Old Fashioned Racism [21] that I think is still an important factor in 




theory of “aversive racism” that states that for whites who subscribe to contemporary, more 
indirect and subtle forms of racism “an indirect attitudinal process operates to increase the 
salience and potency of factors that can substitute for the issue of race in justifying negative 
behavior… in situations involving blacks”[23]. In a later work Gaertner and Dovidio go on to 
explain that: 
The ‘aversive’ in aversive racism therefore reflects two types of aversion. 
Because of the anxiety and discomfort that aversive racists experience, they find 
interracial interaction aversive and try to avoid it…Also, aversive racists, who 
believe that they are nonprejudiced and who consciously embrace egalitarian 
ideals, would find aversive any thought or indication that they might be racist. As 
a consequence, aversive racists are primarily motivated  to avoid wrongdoing or 
acting inappropriately in interracial situations…discrimination will tend to occur 
in situations in which normative structure is weak, when the guidelines for 
appropriate behavior are vague, or when the basis for social judgment is weak 
[27]. 
 
In my study, the acute or ambiguous symptom vignette, that includes several relatively mild 
and common symptoms of SLE (e.g. skin rash, pleurisy) in addition to a mild manifestation 
of lupus nephritis (serum creatinine level just below 1 gram (0.8)) acts as the ambiguous 
case. I hypothesized that the variety of acute or ambiguous symptoms that might be treated 
would offer a physician the opportunity to neglect treating the more serious symptom, lupus 
nephritis, in favor of treatment for one of the other symptoms in the case of black patients. At 
the same time, physicians would take action around the possible lupus nephritis symptoms 
seen in the white patient. Discrimination would thus be on the basis of competing priorities, 
with the order of priority being different for the black patient with acute or ambiguous 




Hypothesis 2: Physicians' mean scores on implicit bias measures will be high while explicit 
measure scores will be low, following the finding that US physicians report high levels of 
unconscious racial and ethnic bias, while reporting low levels of explicit bias [67].  
Hypothesis 3: There will be negative correlation between both implicit and explicit bias and 
favorable treatment decisions for black patients, but not for white patients, and the interaction 
between bias and patient race will be significant. I expected to see a high correlation between 
high levels of explicit discrimination and less efficacious treatment decisions for black 
patients because statements of overt discriminatory beliefs can be seen as clear indications of 
intent toward the discriminated group [132]. There is also evidence that implicit associations 
may be tied to behavior [22, 133, 134].   
Hypothesis 4: Physicians will rate black patients as less compliant, less health literate and 
less knowledgeable than they do white patients. The health literature documents that in the 
United States, blacks are more likely to be poor and therefore perceived by physicians as 
non-compliant; have lower health literacy; and be less knowledgeable than are whites so 
perceived [10] which may lead to differences in treatment. This hypothesis is based on the 
idea that 
An individual difference characteristics such as race or gender acquires ‘status 
value’ when widely held cultural beliefs ‘indicate that persons with one state of 
the characteristic’ are more worthy in society ‘than those with another state of the 
characteristic.’  These status beliefs in turn, can become an important component 
of group stereotypes…relatively low levels worth and competence are attributed 




The hypothesis therefore leads to a secondary assertion that a physician’s negative 








CHAPTER 4: RESULTS 
 
 This study sought to explain physicians’ decision making processes and treatment 
recommendations for women patients with a possible complication of SLE, lupus nephritis, when 
those patients differed by only one observable characteristic, race
28
. Race will be assessed using 
a black-white binary. The conceptual model below (Figure 16) describes graphically the 
direction of causality to be assessed by the analyses in this chapter. The relative positioning of 
the variables from left to right does not represent temporal relationships between or among the 
variables, rather the arrows between variables demonstrate the hypothesized links in the causal 
chain [136].     
The analysis of hypothesis one explores the main study question, whether black patients 
received less optimal treatment recommendations than did white patients (path B) and whether 
the presentation of acute or ambiguous patient symptoms exacerbated a racial disparity in 
treatment recommendations (path E). For hypothesis two, the analysis will look at whether 
physicians do in fact display high implicit and low explicit bias as measured by responses to a 
paper-format Implicit Association Test, a Brief Implicit Association Test, two measures of 
explicit discriminatory beliefs and a measure of motivation to control prejudiced reactions.  
Hypothesis three asks whether higher levels of explicit and implicit bias are correlated with less 
optimal treatment recommendations  
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for black patients, but not for white patients (path A). The analysis of hypothesis four will test 
whether physicians assessed black patients as less knowledgeable, intelligent and compliant than 
white patients (path C) and whether these personal characteristics assessments were predictors of 
poor treatment recommendations (path D). I employed T-tests, Analysis of Variance (ANOVA) 


























The chapter is divided into two sections. First, sample characteristics for the study 
participants are presented; then, results for each of the study hypotheses will be reported in order, 
followed by a brief report of results for some additional questions regarding physician and 
patient characteristics and their relationship with the central hypotheses that will add to the 
understanding of the main findings. The data generated by these additional questions serves to 




 The following are selected findings of the descriptive analysis of demographic data 
collected in both data collections, face-to-face and online; detailed data is shown in Tables 5 and 
6.  Seventy nine (79) respondents or 84% of the sample were born in the United States, while 
16% were foreign born. Almost 40% of foreign born respondents were born in India or Pakistan 
followed by about 22% from the Latin American and the Caribbean region.  Most participants 
were male (59%), white (73%), adult and pediatric rheumatologists (96%) who reported seeing 
the majority of patients in hospital-based clinics (54%). More than 40% of the sample 
respondents were under the age of 40 at the time of response. Finally, most respondents (90%) 
reported that their patient load included 30% or fewer patients with Systemic Lupus 
Erythematosus (SLE).
 







Table 3. Physician Demographics, Frequency and Percentage of Sample 
Respondent Characteristics Frequency (#)  Percent of 
sample (%)















North American 35 38
Eastern European 16 17.4
Western European 13 14.1






60 and above 13 13.8
Doctor of Medicine or Doctor of 
Osteopathy 
100







Table 4. Physician's Demographics continued, Frequency and Percentage of Sample 
 









Systemic Lupus Case Load
Fewer than 10% 31 33
10%-30% 54 57.4
31%-50% 7 7.4
71%-90% [1] 1 1.1
91%-100% 1 1.1
Setting where 60% or more 
patients seen
Private office/private clinic 37 39.4
Hospital-based clinic 51 54.3
Public clinic 3 3.2
Other 3 3.2
Year of Medical School 









Duration in current medical 
position 5 years or fewer 55 59.1
6 yrs – 10 yrs 8 8.6
11 yrs – 20 yrs 16 17.2
More than 20 years 14 15.1
* Totals may not add to 100% because missing values not included.
[1] A typo in the survey rendered these two options: 71%-80% and 




The gender, age and ethnic profile of the sample is consistent with the overall profile of 
US physicians provided by the Association of American Medical Colleges who reported that of 
the 17,364 graduates in 2011, 48% were women and 52% men; 62% were white; 22% Asian and 
6.5% black. A decade earlier, in 2002, the graduation figures were similar. For the 15,676  U.S. 
medical school graduates in 2002, 44% were female and 56% male; 64% were white; 19% were 
Asian and 7% were black [137] (See Table 5).  
  
Table 5. Demographics: Study participants compared with 2011 US medical school graduates 
Respondent Characteristics Frequency (#)  Percent of 
sample (%)*
2011 US Medical 
School Graduates (%)*
Female 38 40.4 48
Male 56 59.6 52
American Indian/Alaskan Native 1 1.1 0.78
Asian 15 16.1 22
Black 4 4.3 6.5
White 68 73.1 62
Other 5 5.4 0.19
Gender
Race
* Totals may not add to 100% because missing values not included.  
A 2005 study of rheumatologists carried out by Deal et.al. found that “male and female 
rheumatologists are equally distributed up to age 44, after which men predominate. The [future] 
trend is for an increasing percentage of women in the adult and pediatric workforce” [138]. The 
study sample conforms to the over 40 description presented by Deal, but presents an unexpected 
overrepresentation of women in the 20-39 age groups. The analysis will not correct for this 
gender imbalance by weighting the responses of males between 20 and 39, as the overall sample 




 The determination of less effective treatment for the following analysis views treatment 
efficacy on a scale from low to high, where a patient who receives a more efficacious treatment 
will be said to have received better treatment. Again, the analysis will prioritize findings in the 
areas of prescription and testing recommendations; only findings in these two areas will be 
considered as confirming the study’s hypotheses.  Findings in other areas will be discussed in the 
context of the study.   
Data Analyses 
 
Hypothesis 1: Physicians will make less efficacious treatment and follow-up recommendations 
for black patients when compared with white patients.  Less efficacious treatment decisions for 
black patients will be greatest when patients present with acute or ambiguous symptoms, rather 






Table 3. ANOVA. The Effect of Patient Race and Symptoms on Physicians' Treatment Recommendations  
(Means with standard deviations in parentheses)a 
Acute Severe
Rx Potency








Race: F=0.53 df = 1; NSb
Symptoms: F=6.52; df=1; p<0.01
Interaction: F=0.02; df = 1; NS
Rx Potency Combo








Race: F=0.06; df = 1; NS
Symptoms: F=9.00; df=1; p<.00
Interaction: F=0.02 df = 1; NS
Invasive Testing








Race: F=0.00; df = 1; NS
Symptoms: F=20.37; df=1; p<.00
Interaction: F=0.00; df = 1; NS
Patient Participation Testing








Race: F=0.20; df = 1; NSb
Symptoms: F=22.21; df=1; p<0.00
Interaction: F=0.01; df = 1; NS
Symptoms
a Higher scores  denote better treatment recommendations .




Table 4. Logistic Regression. The Effect of Patient Race and Symptoms on Physicians' Treatment Recommendations 
(Percentages receiving optimal treatment recommendation)a 
Acute Severe
Visit Recommendation   (visit ≤ 1 month)









Specialist Referral (% of N referred)










a Higher percentages  denote better treatment 
b NS = nons igni ficant  
 
Hypothesis one states that physicians will make less efficacious treatment and follow-up 
recommendations for black patients than for white patients. Following the aversive racism theory 
in which modern racism is most evident in situations where clear social directives are weak or 
absent rather than in circumstances in which social norms dictate the need for equal treatment, 
the hypothesis also states that less efficacious treatment decisions for black patients will be 




symptoms of lupus nephritis. To test these hypotheses, ANOVA and logistic regression were 
used to analyze whether differences in treatment recommendations exist by patient race and 
symptoms and whether race and symptoms have an interaction effect on treatment 
recommendations. The scales for four of the six treatment recommendation variables—
prescription potency; prescription potency with steroid combinations; invasive testing; and 
testing requiring increasing patient participation—have been constructed such that higher mean 
scores indicate “better” treatment. The variables follow-up visit and specialist referral are 
dichotomous and will be reported using logistic regression results and the percentage of each 
race receiving the optimal treatment. Missing variable analysis revealed 11% non-response so 
series means were used to impute missing values.  
ANOVA and logistic regression results (Tables 3 and 4) revealed no significant 
differences between white patients and black patients.  In addition, as expected all of the 
treatment recommendations showed statistically significant differences in treatment 
recommendations among patients with acute versus severe symptoms where the patient with 
severe symptoms received more optimal treatment.  
The second half of hypothesis one states that less efficacious treatment decisions for 
black patients will be greatest when patients present with acute or ambiguous symptoms, rather 
than with more severe symptoms of lupus nephritis, that is, there will be an interaction between 
patient race and symptom type.   Results show no significant interaction effects between race or 
symptoms for any of the treatment recommendations,  
In conclusion, the hypothesis of less overall efficacious treatment for black patients 




differences in treatment recommendations given to black and white patients did not depend on 
the severity of symptoms presented in the vignette. 
Hypothesis 2: Physicians' mean scores on implicit bias measures will be high while explicit 
measure scores will be low. 
  
  





















This  compos ite measure 
sums the responses  to the 
SDO and MRS sca les . 
Because the SDO sca le 
presented in the s tudy has  
more i tems  and a  larger 
range of responses , means  
are influenced more by 
scores  on the SDO sca le.  
Though physicians are not often the subject of social psychological inquiry, there is some 
evidence that physicians’ “implicit and explicit attitudes about race follow the same general 
pattern seen in very large, heterogeneous public samples; the majority held implicit preferences 




race. This weak relationship substantiates the supposition that one may explicitly hold egalitarian 
beliefs while simultaneously holding implicit attitudes that favor Whites relative to Blacks” [65]. 
  The study’s second hypothesis follows these findings stating that mean scores on implicit 
bias measures for the sample physicians will be high while explicit measure scores will be low. 
Specifically, the hypothesis suggests that scores on the paper-format IAT and the Brief Implicit 
Association Test (BIAT) will reflect pro-white bias similar to that  reported for other physician 
samples in the United States [65] and that two of the three measures of explicit social cognition 
measuring the physicians’ orientation toward social dominance and conscious racist beliefs, will 
reflect little to no bias. In order to test the implicit bias hypothesis, I used a one sample t-test to 
determine whether the mean paper-format IAT and BIAT D scores are significantly different 
from 0, or no bias.  
  One sample t-test results show that both mean paper-format IAT scores (t (38) = 1.61;  
p=0.12) and mean BIAT scores (t (29) = -1.54;  p=0.14) are effectively equal to 0 meaning that 
the sample showed no implicit or unconscious bias toward whites or blacks. Paper-format IAT 
scores ranged from -4.71, bias toward black names, to 6.12, bias toward white names, while 
BIAT D scores ranged from -0.788, a slight bias toward black faces, to 0.654, a slight bias 
toward white faces. The observed mean for the BIAT D score, -0.1, fell within the effect size 
range of little to no bias as defined by the BIAT software.  The first part of hypothesis one then 
is not supported; IAT scores reflect little or no bias.  
In addition to implicit measures of bias, the respondents answered a series of explicit 
measures of cognition— four items from the Social Dominance Orientation scale (SDO); four 




the Modern Racism scale (MRS). Each score (SDO, MCPR and MRS) is calculated as the mean 
of the items from the respective measure
29
. The SDO and the MRS scales are direct measures of 
bias, while the MCPR reflects a respondent’s perceived need to “inhibit unintended, automatic 
discriminatory behavior”[139]. Those who report lower MCPR usually display behaviors in 
accordance with their explicit expression of prejudice, while those with high MCPR display 
discordant attitudes and behavior [131].  Here, the SDO scale and the MRS will be considered 
together to reflect low or high explicit bias, as demonstrated in Table 5. Interpretation of the 
MCPR will depend on results for the SDO and MRS. For the explicit bias measures, I will 
present descriptive data to test the hypothesis that participants exhibit low explicit bias, 
comparing the data with that of similar studies. One caveat to these comparisons is that the 
sample respondents in the comparison studies most likely will have been administered the full 
14-item SDO, 10-item MCPR or 7-item MRS, while participants in the current study received 
only a sampling of items from each of these scales. A more appropriate comparison group would 
have responded to the same SDO, MCPR and MRS items to which the participants in this study 
responded. 
As hypothesized, mean scores on the SDO indicate low orientation toward social 
dominance ( = 1.81, 1.00 out of 7 points). This score is lower than the grand mean SDO 
scores for a sample of 1,952 public and private-university students reported by Pratto et. al. 
[128], ( = 2.96, 0.29) and the sample of 114 university students reported by Brown [140] 
( = 2.85, 0.90), but consistent with the finding that SDO is usually lower among those who 
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choose hierarchy-attenuating social roles
30
[128]. The respondents also scored low on the MRS (  
= 1.5, SD= 0.74 of 5 possible points). Also as hypothesized, this MRS score is significantly 
lower than both the sample mean score for a representative U.S. national sample of 600 whites 
related by Brown et. al. [141] (  = 3.02, SD= 0.86) and the mean MRS reported by Poteat and 
Spanierman [142] (  = 2.16, SD= 0.119) for a sample of 342 white college students. Finally, the 
mean MCPR score for the sample was 4.85 (SD=0.98) on a 7-point scale, indicating a low 
motivation toward control. However, this score is relatively higher at 1.93
31
, than the mean 
MCPR found among a sample of 94 undergraduate students by Wyer (  = 0.28, SD= 0.87)[143].  
MCPR was also lower among computer-based participants (  = 4.69, SD= 1.11) than among 
face-to-face participants (  = 4.98, SD= 0.86); the difference in mean MCPR between the face-
to-face and online data collections was not statistically significant. Responses on the SDO scale 
were correlated positively with responses to the MRS (r= 0.441, p=0.000) and both were 
correlated negatively with responses to the MCPR (r=-0.239, p=0.043), such that respondents 
with low social dominance orientation also reported low modern racism and higher motivation to 
control prejudiced reactions (Table 6). This suggests that lower explicit prejudice may be 
downwardly biased by a desire to appear non-prejudiced.   [128]. There were no significant 
differences between the scores of participants who received white patient vignettes and those 
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 Pratto et. al. define “those whose work is primarily aimed at protecting, serving , or benefitting elite members of 
society more than oppressed members of society  “hierarchy-enhancing.” Those whose work benefits the oppressed 





 In order to compare the study’s sample mean to the mean found by Wyer, the mean was converted from scale with 
a maximum score of 7 to a scale with a maximum score of 3, as used by Wyer.  The resulting mean score, 1.93, 




who received black patient vignettes: SDO (F (14, 71) =1.31; p = 0.23): MRS (F (16, 71) = 1.13; 
p = 0.35): MCPR (F (5,71)  = .81; p=0.55). 
  
Table 6. Correlation Matrix SDO, MCPR and MRS 
SDO MCPR MRS




Sig. (2-tailed) . .043 .000
N 72 72 72
Pearson Correlation -.239* 1 -.107
Sig. (2-tailed) .043 . .369
N 72 72 72
Pearson Correlation .441** -.107 1
Sig. (2-tailed) .000 .369 .
N 72 72 72
**. Correlation is significant at the 0.01 level (2-tailed).
Correlations
Social Dominance Orientation (SDO)
Motivation to Control Prejudiced Reactions 
(MCPR)
Modern Racism (MRS)
*. Correlation is significant at the 0.05 level (2-tailed).
 
In conclusion, the data refute the hypothesis that participants had high implicit bias, but 
support the hypothesis of low self-reported bias. Scores on explicit bias measures were lower 
than expected by the researcher, but MCPR scores were relatively higher than expected, 
indicating the possibility that the treatment decisions and assessments analyzed later in the 
chapter may somehow reflect this control, rather than the participants’ automatic response. 
 
Hypothesis 3: There will be negative correlation between both implicit and explicit bias and 
favorable treatment decisions for black patients, but not for white patients. The interaction 









Table 7. Explicit Bias Score by Patient Vignette Race and Symptoms 














Hypothesis three states that there will be a negative correlation between both implicit and 
explicit bias and favorable treatment decisions for black patients, but not for white patients. The 
analysis required the creation of new variables: two interaction variables, the products of patient 
race and the two implicit measures (paper-format IAT and BIAT D score) and an explicit bias 
measure that is the sum of the two explicit measures, SDO and MRS (Table 7). The analysis 
showed this hypothesis to be unsupported.  To assess the hypothesis, each of the treatment 
recommendations was regressed on the bias measures. Linear regression was used for the 
continuous prescription and testing treatment variables and logistic regression was used for the 
dichotomous variables follow-up visit and specialist referral. Regression results showed  
significant positive relationships among high explicit bias and the treatment recommendations 
invasive testing  and testing that requires increasing patient participation (Table 8). Logistic 





Table 8. Linear Regressions of Treatment Recommendations on Explicit Bias Measure 
B r2
Rx Potency -0.04 (0.11) 0.002
Rx Potency Combo -0.05 0.003
Invasive Testing 0.34 0.147*
Patient Participation Testing 0.42 0.157*
1
Al l  6 treatment recommendations  were regressed separately on 
SDO and MRS.  Results  on direction of effect and s igni ficance were 









Table 9. Logistic Regressions of Dichotomous Treatment Recommendations on Explicit Bias Measure 
B (SE) OR (CI) p
Follow-up Visit 0.20 (0.18) 1.22 (0.86, 1.74) 0.28
Specialist Referral 0.20 (0.19) 1.22 (0.84, 1.76) 0.30
Explicit Bias (N=72)
 
Next, to directly test hypothesis three the following interactions were tested with each of 
the six treatment recommendations: patient race*paper-format IAT; patient race*BIAT D Score; 
patient race*explicit bias and patient race*MCPR. There were no significant associations 
between the interactions of race and bias (race*explicit bias) and treatment recommendations. In 
conclusion, the hypothesis of a negative relationship between both implicit and explicit bias and 
optimal treatment recommendations for black patients was unsupported. In fact, it was shown 
that participants who reported higher explicit bias, recommended more, rather than less, optimal 






Hypothesis 4: Physicians will rate black patients as less compliant, less health literate and less 
knowledgeable than they do white patients, and negative assessment will be associated with less 
optimal treatment recommendations. 
 
Table 10. ANOVA. The effect of Patient Race and Symptoms on Physicians' Assessments of Patient Personal Characteristics 
(Means with Standard Deviations in Parentheses)a 
Acute Severe








Race: F=4.89; df = 1; p<0.03
Symptoms: F=0.21; df=1; NSb
Interaction: F=0.03; df = 1; NS








Race: F=8.28; df = 1; p<0.01
Symptoms: F=0.30; df=1; NS
Interaction: F=0.05; df = 1; NS








Race: F=2.48; df = 1; NS
Symptoms: F=1.60; df=1; NS
Interaction: F=0.57; df = 1; NS
b NS = nons igni ficant
a
 Higher scores  denote more association with the 









There is some evidence to suggest that physicians’ negative assessment of black and low 
socio-economic status patients’ character, intelligence and compliance may in part explain some 
common health disparities [147]. Hypothesis three states that physicians will rate black patients 
as less compliant, health literate and knowledgeable than they do white patients and that negative 
assessment will lead to less optimal treatment recommendations.  
To assess this hypothesis, ANOVAs were performed to assess mean differences in 
assessments of patients’ personal characteristics by patient race and symptoms, and linear and 
logistic regression were used to determine whether assessed personal characteristics were 
significant predictors of treatment recommendations. Missing data analysis showed fewer than 
6% missing responses.  However, two respondents skipped this section entirely and three others 
skipped all the items he items on mood, affect, complaining about care and compliance.  In these 
cases, missing data was not imputed, rather deleted pair wise. In this section I will report the 
ANOVA and linear regression results for the personal characteristic variables likely to comply 
with treatment; knowledge; and intelligence as these pertain directly to the hypothesis.  
The ANOVA results in Table 10 show significant differences between participants’ 
assessments of the personal characteristics of their assigned black or white patients for the 
characteristics intelligence and knowledge. Contrary to my prediction, black patients were rated 
more positively than whites for these two variables unintelligent-intelligent (F = 4.89; df = 1; p = 
0.035) and ignorant-knowledgeable (F = 8.28; df = 1; p=0.005). No significant effects for 
symptoms or the interaction of race and symptoms was found. 
Regression results (Tables 11 and 12) show that more positive assessments of patient 




however none of these associations was statistically significant.  A high score on the variable 
unintelligent-intelligent like the scores received by black patients, indicating an assessment of a 
patient as intelligent, was a predictor of worse treatment recommendations for all of the 
treatment recommendation variables.  A high score for the variable ignorant-knowledgeable, an 
assessment of greater knowledge, predicted better prescription and follow-up recommendations 
but worse testing and referral recommendations.  Finally, like intelligence, an assessment of 
greater likelihood of compliance with the treatment plan was a predictor of worse 
recommendations for all of the treatment recommendation variables. None of these results was 
statistically significant.   
  
Table 11. Linear Regression. Patient Personal Characteristics and Treatment Recommendations 
N Rx Potency Rx Potency Combo Invas ive Testing
Patient Participation 
Testing
92 -0.19 (0.18) -0.19 (0.19) -0.07 (0.16) -0.03 (0.20)
92 0.24 (0.17) 0.30 (0.19) -0.17 (0.16) -0.26 (0.20)




Likely to Comply with Tx
B (SE)
 
Table 12. Logistic Regression. Patient Personal Characteristics and Treatment Recommendations 
B (SE) OR (CI) B (SE) OR (CI)
Unintelligent-Intelligent -0.01 (0.26) 0.98 (0.60,1.66) -.02 (0.30) 0.98 (0.55, 1.77)
Ignorant-Knowledgeable 0.12 (0.26) 1.11 (0.68, 1.86) -0.14 (0.30) 0.87 (0.49, 1.55)
Likely to Comply with Tx -0.09 (0.29) 0.92 (0.52, 1.62) -0.21 (0.32) 0.81 (0.44, 1.51)
Follow-Up Visit (n=90) Specialist Referral (n=91)
 
In conclusion, the hypothesis of pro-white bias in assessment of patients’ personal 
characteristics was incorrect. Black patients were rated more positively than white patients on all 




despite positive assessments of black patients’ personal characteristics, in most cases it was more 
negative personal characteristic assessments that predicted better treatment recommendations, 
but the associations found were not statistically significant. The results of this sample’s character 
assessments are highly counterintuitive when the results of similar studies are taken into account  
[61, 144] because in this sample, physicians’ evaluations of their patients’ personal 
characteristics revealed a positive bias toward black patients, but not strictly “against” white 
patients, who received more neutral scores. 
 
Summary of Main Findings 
 
The data have shown most hypotheses to be unsupported. There was no difference in the 
treatment recommendations made for black and white patients and further, no evidence that 
treatment recommendations for black vs. white patients varied by symptom type, acute vs. 
severe.  Physicians did not display high implicit or unconscious bias; they scored in the range of 
little to no racial bias on both the paper-format IAT and the BIAT. Black patients were not rated 
lower than whites with regard to the personal characteristics intelligence, knowledge and 
compliance and there was a non-significant negative, not positive, relationship between personal 
characteristics assessment and treatment recommendations.  Finally, I found no negative 
relationship between either implicit or explicit bias and favorable treatment recommendations for 
black patients.  I did find  that explicit bias scores for the physician respondents for the study 







In the following section, I will describe briefly the analysis of three additional findings 
that are relevant to the understanding of the treatment decisions made by physicians in this study 
and will present the results of the analysis of Hypothesis 1 by data collection method, face-to-
face and online. The section focuses primarily on the role of physician and patient demographics 
on bias scores, treatment recommendations and assessments of patients’ personal characteristics. 
Following this, the results of the analysis of differences in the assessment of patient 
characteristics by patient symptoms and a measure of patient physical attractiveness will be 
related. The section also reexamines hypotheses one, the study’s central hypothesis, both without 
the inclusion of the “brown patients” from the American College of Rheumatology pilot and by 
data collection method.  Figure 17 demonstrates the relationship among these supplementary 











































The study’s first supplemental question asks whether physician race influenced the 
relationship between patient race and treatment recommendations (Path F). Question two asks if 
the physical attractiveness of the model used to represent the black patient influenced the very 
positive assessments of her personal characteristics (Path G). Finally, question three returns to 
the main study question (Path B) and analyzes treatment recommendations when the “brown” 
patient is eliminated from the data analysis, changing the assumptions about racial assignment as 
described in the Methods Chapter. The final analysis also looks at the study’s main hypothesis, 
asking whether the method of collecting data, either face-to-face or online, may have influenced 
the relationship between patient race and treatment recommendations (Path H). Each of these 
additional analyses will contribute to an understanding of how study participants made treatment 
decisions and how their personal characteristics may have affected the decision making 
processes.  
 Physician Race and Treatment Recommendations 
 
In this section, I will look more closely at physician race and explore how race 
concordance between physician and patient might have affected treatment recommendations.  
Specifically, the section will explore whether treatment of black patients by nonwhite physicians 
produces better outcomes than were shown in the main data analysis in which the predominance 
of white physicians may have overshadowed racial differences in care between and among 
physician participants. The literature on health disparities speaks often of higher patient 
satisfaction with physicians of the patient’s own race, though these findings are nuanced [8, 
145]. ANOVA and logistic regression were used to assess the impact of race concordance on 




physicians with white patients; white physicians with black patients; other race physicians with 
white patients; and other race physicians with black patients. ANOVA results showed significant 
differences in physician-patient race pairings for the treatment variables invasive test (F (3,92) = 
4.455, p = 0.006) and testing that requires increased patient participation (F (3,92)=4.174, 
p=0.008). For each of these significant treatments the black patient-non-white physician pairing 
had the highest mean score, indicating better treatment
32
. No significant differences in physician 
race-pairings for follow-up testing or specialist referral were found.  
Tukey’s HSD post-hoc tests showed that for invasive testing there were significant 
differences between the black patient-non-white physician pairing (  difference =4.25, SD=1.0) 
and the white patient-non-white physician pairing (  difference =3.0, SD=1.0, p=0.085), such 
that the black patient assigned to other race physicians received better treatment recommendation 
for invasive testing than did the white patient assigned to the other race physicians. There were 
also significant differences seen between the black patient-nonwhite physician pairing and the 
black patient-white physician pairing (  difference =3.14, SD=1.407, p=0.017). An additional 
difference between the black patient-non-white physician pairing (  difference =4.25, SD=1.0) 
and the black patient-white physician pairing and the white patient-white physician pairing (  
difference =3.92, SD=1.176, p=0.078) for invasive testing was identified such that black patients 
seen by other race physicians received better treatment recommendations for invasive testing 
than other black patients seen by white physicians. In the relationships above, the mean 
difference in treatment was greatest between black and white patients seen by other race 
physicians (  difference =1.25, SE=0.522). Table 13 shows the means and standard deviations 
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for each of the patient-physician combinations analyzed for the dependent variable invasive 
testing.  







For testing that requires increased patient participation Tukey’s HSD identified two 
significant differences: between the black patient-non-white physician pairing (  difference 
=3.88, SD=1.5) and the white patient-non-white physician pairing (  difference =2.22, 
SD=1.093, p=0.05), such that again black patients assigned to other race physicians received 
better treatment recommendations for testing requiring increased patient participation than did 
white patients assigned to other race physicians . An additional difference was identified between 
black patients assigned to non-white physicians and black patients assigned to white physicians 
(  difference =2.63, SD=1.543, p=0.030). Again, black patients assigned to non-white physicians 
received better treatment recommendation for testing requiring increasing patient participation. 





Black patient with 
white phys ician
3.140 .191 2.760 3.519
Black patient with 
non white phys ician
4.250 .313 3.628 4.872
White patient with 
white phys ician
3.917 .256 3.409 4.425
White patient with 
non white phys ician
3.000 .417 2.170 3.830
RACE CONCORDANCE
Dependent Variable: INVASIVE TEST






assigned to non-white physicians and white patients assigned to non-white physicians (  
difference =1.65, SE=0.630) (Table 14).  
  





Black patient with 
white phys ician
2.628 .231 2.170 3.086
Black patient with 
non white phys ician
3.875 .378 3.124 4.626
White patient with 
white phys ician
3.458 .309 2.845 4.072
White patient with 
non white phys ician
2.222 .504 1.220 3.224
RACE CONCORDANCE
Dependent Variable: TESTING THAT REQUIRES INCREASING PATIENT 
PARTICIPATION




Therefore, black patients assigned to other race physicians received better treatment 
recommendations than both white patients seen by other race physicians and white patients 
assigned to white physicians. Though a little less than a third (27%) of study participants were 
non-white, almost two thirds of these non-white participants received black patient vignette 
(64%). It seems that the participation of non-white physicians may have influenced the findings 
of no difference between black and white patients. 
Patient Physical Attractiveness and Assessment of Personal Characteristics 
 
An unintended consequence of the selection of individual models to represent the patients 
for the study vignettes was that assessments of models’ physical attractiveness may have been a 
significant factor in the assessment of patients’ personal characteristics. In fact, an external 




independent evaluators (62% male)
33
, revealed a difference in the evaluation of physical 
attractiveness between the models used to represent the black patient and the white patient, 
where all races and genders scored the black patient higher in attractiveness than the white 
patient.  
Social psychological studies have shown that physical attractiveness can influence both 
assessments of personal characteristics and the likelihood of engaging in helping behavior 
toward an unknown individual [146]. This section analyzes whether the physical attractiveness 
of the models may have influenced the assessment of their personal characteristics. In order to 
address this question, personal characteristic variables adjusted to eliminate the effects of 
physical attractiveness as rated by the panel described were created by subtracting attractiveness 
scores from personal characteristics scores.  Attractiveness was scored in the following way: 
white patients assigned to nonwhite physician respondents were given an attractiveness score of 
4.71; white patients assigned to white doctors were given an attractiveness score of 5.32; black 
patients assigned to nonwhite physician respondents were given an attractiveness score of 7.64; 
and black patients assigned to white physician respondents were given an attractiveness score of 
6.63. The scores assigned correspond to the mean scores given to the patient models by the 
attractiveness survey respondents
34
. The goal was to produce a counterfactual in which physical 
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 About 29% of the sample or 10 respondents saw a different “white” photo during the American College of 





 White respondents to the attractiveness survey gave the white patient model a mean attractiveness score of 5.32 
and black respondents gave the white patient model a mean score of 4.71.   White respondents to the attractiveness 
survey gave the black patient model a mean score of 6.63 and black respondents gave the black patient model a 




attractiveness was the same for both patients. ANOVA was used to test differences in 
assessments of the adjusted personal characteristic variables.  
ANOVA results show that differences in mean personal characteristics scores by patient 
race for the variables intelligent and comply were no longer significant when patient physical 
attractiveness was removed from consideration. The present finding of no difference, suggests 
that the relatively higher attractiveness of the black patient photo, may have played in a role in 
the higher scores given to her for intelligence and compliance.  The variable knowledge, 
however, remained significant after removing the effects of physical attractiveness (F 
(1,92)=6.034, p= 0.016), such that black respondents were given higher mean scores for 
knowledge (  =4.76, SD=1.21) than were white patients (  =4.07, SD=1.44) . This result was 
similar to that found when attractiveness had not been removed from consideration.  
So, there is some evidence that patient physical attractiveness may have inflated the 
assessment of personal characteristics for the black patient with relation to the items 
unintelligent-intelligent and likely to comply with treatment. This finding puts in context the 
seeming incongruity between the positive assessments of the black patient’s intelligence as a 






Exclusion of Brown Patient and Treatment Recommendations 
Table 15. ANOVA. The Effect of Patient Race and Symptoms on Treatment Recommendations with Brown Patient Omitted 
(Means with Standard Deviations in Parentheses)a 
Acute Severe
Rx Potency








Race: F=0.5 df = 1; NSb
Symptoms: F=7.62; df=1; p<0.01
Interaction: F=0.23; df = 1; NS
Rx Potency Combo








Race: F=0.16; df = 1; NS
Symptoms: F=10.93; df=1; p<.00
Interaction: F=0.41 df = 1; NS
Invasive Testing








Race: F=0.02; df = 1; NS
Symptoms: F=21.30; df=1; p<.00
Interaction: F=0.01; df = 1; NS
Patient Participation Testing








Race: F=0.00; df = 1; NSb
Symptoms: F=21.68; df=1; p<0.00
Interaction: F=0.01; df = 1; NS
a Higher scores  denote better treatment recommendations .






Table 16. Logistic Regression. The Effect of Patient Race and Symptoms on Treatment Recommendations with Brown Patient 
Omitted (Percentage receiving more optimal treatment recommendation)a 
 
Acute Severe
Visit Recommendation   (visit ≤ 1 month)









Specialist Referral (% of N referred)










a Higher scores  denote better treatment 
b NS = nons igni ficant  
In the Methods Chapter I described the process by which I decided to add results for the 
brown patient to those of the black patient photo for data analysis.  The following analysis looks 
at treatment recommendation results when I exclude from the analysis of the black patient the 12 
instances during the face-to-face data collection when a participant received the brown patient 
vignette. Tables 15 and 16 show the new means, standard deviations and percentages for black 




including the brown patient). There is no change in the means, standard deviations and 
percentages for white patients. In most cases, mean treatment recommendations for black 
patients fall and consequently white patients receive more optimal treatment recommendations 
for most of the treatment variables. The fall in treatment recommendation quality is most 
extreme for black patients with acute or ambiguous symptoms. 
  As was the case with the main analysis, ANOVA and logistic regression results in Tables 
15 and 16 show significant main effects for patient symptoms for all continuous treatment 
recommendations and no interaction effects or dichotomous treatment variable effects. ANOVA 
and post-hoc (Tukey) analysis of differences between black and white patients with acute 
symptoms for continuous dependent treatment variables showed no significant differences in 
treatment recommendations between the two groups.  
To conclude, excluding brown patients from the data analysis did, in fact mean that black 
patients received less optimal treatment recommendations than white patients for most 
recommendations as measured by group means, but as in the original analysis, no statistically 
significant difference between blacks and whites was found in treatment recommendations.  
Data Collection Method 
 Because the data collection methods may have introduced bias into the study, an issue to 
be included in the Discussion, I am including a summary of findings from the ANOVAs and 
logistic regressions run for Hypothesis 1, the study’s central hypothesis, by data collection 
method, face-to-face at the American College of Rheumatology conference or online. The result 




Conclusion   
In conclusion, these additional findings provide nuance to the results of the analysis of 
the main hypotheses. First, the additional analysis revealed that black patients received better 
treatment recommendations than white patients when their cases were seen by non-white 
physicians and at the same time they received worse treatment recommendations than white 
patients when seen by white physicians (see Tables 13 and 14). The relatively large cohort of 
non-white participants, when compared with the US rheumatologist demographic profile, may 
therefore have influenced the lack of findings in the main study. Second, the main study data also 
did not support the hypothesis that black patients would be perceived as less compliant, less 
knowledgeable and less intelligent than white patients, but additional analysis showed that 
patient physical attractiveness played an important role in the positive assessment of the black 
patient’s personal characteristics. When patient attractiveness was removed from the 
assessments, black patients were scored higher than whites only for the variable knowledge. 
Finally, the data showed that removing the brown patient from the black sample reduced the 
quality of treatment recommendations made for black patients’ but there continued to be no 
statistically significant difference between black patients and white patients.  Similarly, data 
collection did not significantly influence the relationship between patient race and treatment 
recommendations. By providing a context for the unsupported hypotheses of the study, these 
additional questions have improved understanding of the relationships in question. In addition, 
the final analysis puts to rest the question of whether the inclusion of the brown patient photo 
from the face-to-face data collection was responsible for the lack of findings.  The data shows 





 For the most part, my results did not show evidence of bias against black patients in 
treatment recommendations.  Results reported in this section suggest that two methodological 
issues, namely the greater physical attractiveness of the black patient photo and the inclusion of a 
relatively large number of non-white physician participants, may have biased results against 





CHAPTER 5: DISCUSSION 
 
 
 Most of the results reported in the Results Chapter did not support the hypotheses that 
this study was designed to test. Below, I will briefly describe the limitations and strengths of the 
research and data collection methods and provide recommendations for further research.  
Central Hypotheses 
 The central question of the study was whether physicians would make different and less 
optimal treatment recommendations for black patients than white patients. Related to this central 
query were two questions that were hypothesized to contextualize any racial disparity in 
treatment recommendations found between black and white patients: the attribution of 
stereotypical personal characteristics and attitudes and the level of physicians’ implicit and/or 
explicit discriminatory biases.  
The data did not support the hypothesis that black patients would receive less optimal 
treatment. The descriptive data showed black patients ahead of white patients in 
recommendations for prescription and testing, the two recommendations prioritized to provide 
strong evidence of important differences in treatment by race. After removing the brown patient 
from the analysis, mean scores for treatment recommendations for white patients were more 
positive than those for black patients for four of the six treatment recommendations: prescription 
potency; prescription potency with steroid combinations; recommendation for invasive 
treatment; and recommendation of treatment that requires increasing levels of patient 




Drawing on the conclusions of Green et. al. who questioned cardiology residents on their 
recommendations for thrombolysis for 50-year old men presenting with chest pain [67] as 
described in a written vignette with photo, I suggest that the finding of no difference in 
prescription and testing recommendations between black and white patients can be seen as a 
manifestation of bias, though this was not my main hypothesis. In the Green study, respondents 
were randomly assigned either to a white patient or to a black patient vignette. Although no 
difference in the prescription of thrombolysis was found, the authors suggest that equal treatment 
in the face of black men’s disproportionate risk of coronary artery blockage constitutes a 
disparity [67]. Similarly, black women, disproportionately represented among SLE patients, are 
at a greatly increased risk of having LN progress to end-stage renal disease (ESRD) and early 
mortality when compared to whites [87, 147]. The finding of no statistical difference in treatment 
recommendations for prescription and testing between white patients and black patients, when 
blacks have a higher risk for adverse outcomes from lupus nephritis than do white patients, may 
also constitute a disparity worthy of underlining in this discussion [15]. 
  
 
Good Looks? Good Patient 
 
 There are a small number of studies that have looked at physicians’ assessments of black 
and white patients’ personal characteristics, either as stand-alone questions about the 
stereotyping of black and white patients or as part of larger studies of physician decision making 
[61, 62, 65, 67]. Most of these studies, both direct and indirect, find that on average physicians 
rate black patients more negatively than whites, especially on intelligence and compliance [144] 




study found the opposite:  black patients were rated significantly more positively than white 
patients on almost all measures of personal characteristics. Two possible explanations for the 
study’s unconventional findings follow. 
First, none of the studies I cite above was conducted using only women patients. Jaeger 
documents that physical attractiveness (height, facial attractiveness and body mass index (BMI)) 
confers some advantages over the life course [149]. For women in Jaeger’s study the salient 
factors in socioeconomic status were facial attractiveness and BMI, while for men height and 
BMI played a greater role. Naomi Wolf refers to the scrutiny of women’s facial beauty and BMI 
as a means of social control over women’s bodies. She continues that the “beauty myth is not 
about women at all. It is about men’s institutions and institutional power…it is an expression of 
power relations in which women must unnaturally compete for resources that men have 
appropriated for themselves” [150].  The data supported the conclusion that the black patient’s 
perceived physical attractiveness played a role in her positive personal characteristics 
assessments.  Her looks, however, did not provide her with any advantage in treatment because 
more negatively assessed patients received better treatment recommendations. Of the three tested 
patient characteristics—knowledge, intelligence and compliance—a difference in assessment by 
patient race remained for only knowledge after controlling for patient attractiveness.  So one 
likely explanation for physicians’ positive assessments of the black patient’s personal 
characteristics over the white patient’s may lie in differences in physicians’ perceptions of their 
patients’ physical attractiveness. The strength of the influence of attractiveness is such that 
Jaeger recommends the treatment of attractiveness as an independent explanatory variable in 
social stratification research [149].  It is the salience of attractiveness and gendered stereotypes 




taken into account in studies of racial disparities. Unfortunately, the tendency thus far in 
disparities research has been for measures and studies of discrimination to subsume black 
women’s particular experiences by those of black men’s [100].  
 
Overcompensation 
A second explanation for black patients’ extremely positive personal characteristics 
assessments may lie in a phenomenon called overcompensation. Dutton and Lake describe 
overcompensation, also called reverse discrimination, in the following way: 
 
Reverse discrimination…is…an attempt by whites who think racial prejudice is 
undesirable and who are threatened by the possibility that they themselves might 
be prejudiced to prove to themselves through their behavior toward a black that 
they in fact are not prejudiced…This phenomenon is signified by threatened 
whites making more favorable responses to blacks than to other whites [151].  
 
Overcompensatory (or reverse discriminatory) mechanisms serve the actor because that they 
restore in him or her a sense of social justice in the face of the assumption that colleagues will 
discriminate against the out-group member [152], they also fill the actor’s desire to avoid the 
guilt of participating in a possible racist act, therefore upholding an image of her- or himself as 
non-prejudiced [151]. 
Seemingly in support of the overcompensation explanation, one participant related: 
“when I became aware of the race component I probably became more careful on later sections” 
(Respondent 4224, white male, 40-49). The object of the physician’s carefulness is not named, 




that the study included a racial component. Dutton and Kafka make clear that overcompensation 
may be one of the possible consequences of this conscious choice to appear non racist.  
When over compensatory mechanisms are not taken into account, it is easy for 
researchers to conclude that participants are unbiased or even that whites are disadvantaged due 
to their significantly lower scores on the measure under analysis. I suggest below that measures 
of over compensatory tendency be developed and measured as a part of future research into 
health disparities. The measurement of reverse racism in health disparities research will become 
all the more important as the physician population undergoes a demographic shift toward 
younger physicians exposed to issues of cultural competence and the literature on health 
disparities in medical school, but who, despite this cursory exploration of difference, will not 
necessarily be equipped in any way to reduce health disparities in their day-to-day practice. 
Study Limitations 
 
Though the study was designed to answer the hypotheses presented, there were several 
aspects of the study that would perhaps have yielded different results had they been designed or 
executed differently. I have grouped the study’s limitations into two categories:  researcher 
oversights and sample size. The first limitation is related to decisions made in study design and 
data collection; the inferiority of the paper-format vignette to the video vignette; and the 
salience of the scales used to measure bias, each of which were created more than two decades 
ago. The second limitation details possible sources of error resulting from the study’s small 










The study whose methods and results I reported in this dissertation is a modification of 
my original dissertation proposal to compare treatment recommendations for black and brown 
women (preta and parda) in Brazil with treatment recommendations for the same women in the 
United States. The dissertation would have hinged not only on the differences in treatment 
recommendation by patient race, as I the researcher defined it, but on the Brazilian physicians’ 
differing assignments of race to the parda and their impacts on her treatment recommendations. I 
hypothesized that in Brazil, the parda (mixed race, black and white) would receive less optimal 
treatment similar to that of the black patient, despite the racial classification she was given. My 
goal was to show that the seemingly complex Brazilian racial classification system functioned 
similar to that of the US system in that its main axis of decision making remained white (and 
Asian) and non-white/Asian.  However, after complications with my IRB application to the 
Conselho Nacional de Saúde in Brazil and having been denied the opportunity to conduct data 
collection activities at the Sociedade Brasiliero de Reumatologia ‘s (SBR) 
35
 annual Congress in 
2011, I decided to focus the dissertation only on the U.S. 
One result of the decision to narrow my geographical focus was that I simplified the 
questionnaire meant originally to identify differences in basic treatment recommendations 
available both in Brazil and in the United States and physicians’ racial assignment of patient 
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 The Conselho recommended that I work with a Brazilian Institution in order to carry out the study and apply to 
that Institution’s IRB.  Living in Latin America, I knew that, despite my connections to SEPPIR, the Secretary of 
Racial Equality in Brazil, arrangements to set up the study could take years.  I was not willing to take that time to 
finish the dissertation.  In addition, the medical conference culture in Latin America has not yet and may never 
include an Expo filled with pharmaceutical and NGO booths.  The conference director i) did not understand how I 
would collect data at the Conference, although he offered to share the registration booth with me and ii) why I could 
not just come to hand out flyers rather than conducting the entire experiment at the Conference.  As the study 
required privacy and a trip to Vitória, Espiritu Santo, required a financial investment on my part, I decided against 




photos, rather than the fine nuances of treatment. One consequence of this simplification was the 
omission of hydroxychloroquine (Plaquinil), an anti-malarial used to control SLE symptoms in 
the U.S., from the list of prescription possibilities presented to the physicians because the use of 
anti-malarial drugs was fairly recent in the SLE literature in Brazil. Unfortunately, after the 
exclusion of Brazil from the study, I neglected to add Plaquinil to the list of possible prescription 
options for the U.S. only study. All of the physician participants who recommended Plaquinil, a 
very appropriate drug for the treatment of early stage LN, therefore, wrote in their 
recommendation. The write in responses were numerous enough to merit the inclusion of 
Plaquinil in the data analysis, but the exclusion of this common treatment as an answer choice 
may have underestimated the number of physicians who would have chosen this response had it 
been made explicitly available. The oversight also influenced my decision to eliminate a measure 
of treatment appropriateness for acute or ambiguous cases that showed overwhelming bias 
against black patients with acute or ambiguous symptoms in the prescription of Plaquinil, as 
again, the number of respondents was most likely underestimated. Any replications of this study 
would have to include hydroxychloroquine (Plaquinil) as a response choice for prescription 
recommendation. 
An additional non-finding in the study was that of no implicit bias despite the clear 
finding of implicit bias reported in many studies of physicians. I attribute the lack of finding in 
this areas to priming that may have occurred either because of the order of study elements or 
because of my presence as a black woman, especially during the ACR face-to-face data 
collection. I paid great attention to the placement of the IAT and explicit discriminatory 
measures in the study design. My concern was that both direct and indirect questions to 




threat in white respondents. The plan was to leave all of the discriminatory bias items until the 
end of the study to address the priming concern. However, in the face-to-face data collection, 
logistical concerns led me to have respondents do the paper-format IAT before beginning the 
survey. It was easier to keep track of respondents in a small space at the beginning of our 
interaction rather than when they were ready to leave after completing the online questionnaire. I 
was certain that both the placement of the IAT before the experiment and my presence as a black 
woman would serve as race primes, but I felt that I had little choice under the circumstances. I 
did not, however, expect the same behavior from the computer-based respondents, as their BIAT 
and explicit race questions came at the end of the experiment as planned. There, I made an error 
in not also identifying the addition of demographic questions about the physician’s race and 
ethnicity as possible race primes, nor factoring in that online respondents could Google my name 
and see my race
36
. Asking or reminding a person about her own race and/or ethnicity can serve 
as a prime for stereotypical or vigilant behavior [153] as can the presence of a black researcher 
[96] and this study element may have been the reason for respondents’ discomfort while 
completing the survey, even for those who saw the white patient. These factors may also have 
influenced the finding of no implicit bias, despite the clear findings of implicit bias is many other 
studies. Future studies should be place demographic questions about physicians’ race at the end 
of the survey in order to reduce possible priming effects and be carried out with less researcher 
information, if possible, or employ white research assistants to carry out data collection. 
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In addition, it is very possible that the physician respondents are not as unconsciously 
biased as I hypothesized, as there is no evidence that the respondents faked the results of their 
IAT (paper-format and BIAT) tests.  As I will discuss further on with regard to redefining 
modern racism, further studies should update not only measures of discriminatory belief, but also 
hypotheses about the extent to which whites and others hold unconscious and conscious racial 
discriminatory beliefs.  An additional explanation may lay in the upsurge in literature around 
racial disparities in health care, some of which clearly prescribes different interventions based on 
a patient’s phenotypic race. Perhaps the health disparities literature has contributed to sensitizing 
physicians to the possibility that their biases may produce worse outcomes for black patients or 
at least raised awareness of black patient’s higher risk for mortality from complications of LN, 
causing physicians to pay more attention to back patients with these symptoms. 
 
Vignettes 
Study limitations related to the decision on the type of vignette used to describe patient 
symptoms and the content of the vignettes themselves may have impacted the construct validity 
of the study because participants’ understanding of the cases presented would have differed from 
mine, thus rendering the analysis and findings of little use in describing the hypothesized 
relationships. Little debate remains about the superiority of the video vignette format to the paper 
format vignette in portraying patient symptoms that are more true to life, allowing physicians to 
assess not only the written word, but also body language as part of their treatment considerations 
[61, 62]. This study used a paper-based vignette with photo due to cost considerations, but there 
were various alternative options for presenting the vignette, including presenting the participants 




et, al, study [154]. In the limited literature on the influence of racism on treatment 
recommendations, neither the study that used a written vignette (Sabin, et. al.) nor the other that 
used the written-vignette with picture (Green, et.al. [155]) found any racial differences in 
treatment. My choice to add the picture to the written vignette reflected more the belief that 
presenting a picture was the method closest to that of the video vignette, the method under which 
it is believed that physicians’ actual behavior in medical settings would be better measured [61, 
62].  In fact, as is shown in Table 17, the two studies reporting that used video vignettes showed 
more clear cut racial and gender bias than the studies using paper vignettes [65, 67].  I may have 
found the same or similar results had I used only written vignettes without patient photos, but 
there is little evidence that the written vignette without photos would have produced superior 
results. 
Several of the physicians noted that the vignettes did not provide details on the patient’s 
past lab values as a guide for comparison of current laboratory data. This highlights a potential 
limitation of the study in that participants may not have been able to clearly identify the 
symptoms, especially the acute or ambiguous vignette, as acute or severe lupus nephritis (LN). 
The provision of past laboratory results is a convention adopted in some medical research that 
provides much more clarity to the physician about the trends in the patient’s health.  Though for 
all intents and purposes a serum creatinine level of .8 grams/ddl may be high for an otherwise 
healthy woman, many lupus patients have some kidney damage that requires physicians to 
exhibit increased tolerance for higher than normal serum protein levels in their SLE patients. 
Had the vignettes made clear that the creatinine levels represented a recent spike in blood protein 
in the case of the severe symptoms or a gradual increase, in the case of the acute or ambiguous 




Despite these oversights, I should note that the vignettes used for the study were read and edited 
by two rheumatologists, thus assuring me that the content was generally understandable.   In 
addition, the ambiguity caused by a lack of background data on the patients may not be too far 
from reality as many lupus patients, especially in large cities, see rheumatologists in the context 
of hospital-based lupus clinics where physicians face severe time constraints that reduce their use 
of clinical information in the medical encounter [156].  There is also some suggestion that 
specialist physicians may not need complete historical information in order to ensure quality care 





 In the Methods Chapter, I established that the scales for the six treatment 
recommendations variables would be ordinal, with lower scores signaling less optimal treatment.  
There is a clear limitation to this method, however, especially as applied to the prescription 
treatment recommendations.  In consultation with Jon Giles, I decided to allow the scale to 
increase from less to more potent medications and medication combinations.  However, the 
assessment of more potent treatments as “better” is perhaps a subjective decision.  First, why are 
more potent medications “better”? According to the American College of Rheumatology, more 
potent treatments at least in the case of lupus nephritis are more efficient and efficacious, but 
more potent drugs may also cause more severe side effects including infertility, diabetes and 
blindness [91]. For the purposes of this study, more efficacious treatment is the desired result, 




be that physicians who chose less efficacious treatments were considering issues of patients’ 




      Two of the five measures used to relate physicians’ implicit and explicit discriminatory 
beliefs were noticeably dated and required some adjustment before application to the research. 
For the paper-format IAT that includes a comparison of “white” and “black” names, I eliminated 
out-of-date names like “Leroy” and ambiguously racial names like Justin, reducing the number 
of names available from which respondents could choose and perhaps also reducing the validity 
of the measure. The paper-format IAT was clearly created before the 1990s when names like 
Leroy were common in the African American community and when Arab other Muslims were 
not a significant US immigrant population
37
. In fact, some of the South Asian physician 
respondents marked Malik “incorrectly” as a “white” name. Lemm is clear that the use of the 
paper-format test is useful under certain circumstances, including where technology cannot be 
used to collect responses and where budget constraints hinder the collection of computer-based 
IAT data [127]. So because it is likely that use of the paper-format IAT will continue because of 
budget constraints, particularly the “black” names used need updating.  
 The Modern Racism scale was created in 1986 to much acclaim. But almost thirty years 
later, the question wording is cringe-inducing. For example, “Blacks are getting too demanding 
in their push for equal rights.”  When the country has a bi-racial President and blacks are present 
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in almost all spheres of public life, this statement sounds very similar to “Old Fashioned 
Racism.”  The datedness of this scale also spurred me to limit the number of questions from it 
that I posed to the respondents, as I was certain that many of the scale items would elicit high 
levels of reactivity. It may be time to conceive of a Post-Modern Racism Scale that can reflect 
the tenets of aversive racism as well as the seeming social advances of some blacks in the 
context of continued negative media images of blacks and the continued social and economic 




The final limitation of the study about which I will speak is in the sample size. I had 
planned to recruit at least 200 participants to complete the study and the discrimination 
measures, but of over 3,000 invitations, I received 101 responses, a less than 3% response rate. 
Although the sample size was sufficient to detect small effect sizes for my central hypothesis that 
black patients would receive poorer treatment recommendations than whites, only two thirds of 
respondents answered the explicit and implicit bias items, reducing the study’s power to detect 
differences in treatment recommendations by physicians’ discriminatory beliefs, and additionally 
important element of the study. Had the original sample size been attained, and two thirds of a 
sample of 200 responded to the BIAT and explicit bias questions, the power and external validity 








The study also has several strengths when compared with similar published studies 
(Table 20). First, this is the first study of its kind to question exclusively specialist physicians on 
their treatment recommendations. This distinction is important given the rise in specialized 
medicine and the decline of the generalist [158]. Future studies such as this one, will establish 
whether health disparities function differently given the specialist’s expertise and range of 
experiences with varied disease presentations.   
Second, this study is the first to look for disparities not only by race or by gender but also 
by race and symptom. That is to say that the results of the study have pinpointed a point of 
intervention (early stage lupus nephritis) that could ostensibly reduce disparities. In addition, this 
is the first study of its type of a disease that affects women almost exclusively (8:1) and for this 
reason it is the only among the studies cited to present solely women patients.  
Finally, this is the first study to address the possibility that health disparities may affect 
young adults and as a result may have an impact on life trajectories over a long time horizon 
[159]. The 5-to 10-year renal survival rates in black patients have been identified as 50% and 
38%, respectively, but are74% and 68% in white patients [147]. That is to say that by age 27, 
more than half of the 22-year-old black patients seen in this study would have died despite 
positive assessments of their personalities and follow-up appointments of less than one month. 
Those women who pass the 5 year mark and beyond face diminished life chances over a time 
horizon four times longer than that of the elderly cardiovascular disease  “patients” in the Arber, 







Table 17. Physician Bias in Treatment: Comparison of Literature with Present Study 
Armbris ter (2013) Arber, et. a l . (2006) Green et. a l . (2007) Sabin, et. a l . (2008) Schulman, et. a l . (1999)
N 94 256 220 95 720
Location
American Col lege 
of Rheumatology 
Meetings , 2011 
and nationwide 
recruitment
UK and US.  US 
recruitment in 
Massachussetts
4 medica l  centers  
in Massachussets  
and Georgia
1 department in a  
large univers i ty 
hospita l
American Col lege of 
Phys icians  Meeting 




Internis ts  and 
Fami ly 
Practi tioners
Internal  Medicine 
and Emergency 
Medicine Pediatricians
Internis ts  and Fami ly 
Practi tioners
Field (fi rs t author)
Sociology/Publ ic 
Health Sociology Biomedicine Socia l  Work Biomedicine
Disease/symptom














Patient Gender Female Male/Female Male Male/Female Male/Female
Patient Race Black/White Black/White Black/White Black/White Black/White
Patient Age (years  of age) 22 55 or 75 50 chi ldren 55 or 70
Race and Gender Findings
No s igni ficant race 
findings





and treatment No race findings
Race di fference 
only in treatment 
of UTIs  where 
black patients  




often to black women 
patients  
So, in this discussion I have shown that patients’ race was not the only factor involved in 
physicians’ assessments of their patient’s personal characteristics and subsequent treatment 
recommendations. I underlined the importance of patient physical attractiveness, study design 
and methodology and stereotype threat and overcompensation (reverse racism) on the part of the 
physician respondents as key factors in predicting the study’s findings. Through this discussion I 
hope to leave with the reader the impression that the physician-patient dyad is complex. This 
relationship operates both at the micro- [160] and macro-social [53] levels where personality, 
mood, history, resource availability and social standing collide. Physicians play an important role 
in defining this dyad, but they do not play the only role. Unfortunately, few effective 
interventions have been identified to assist physicians in both understanding their role and 
contribution to the tone set within the medical interaction and in assuring that treatment 




interaction, especially if  those emotions reflect the physician’s discomfort with her patient’s 
social presentation. 
 Finally, as stated briefly above, the study opens the conversation on aversive racism [23, 
25, 27] in the medical space. The findings underline that health disparities are not cut and dried, 
but rather that health disparities may be perpetuated by the heaping on of disadvantage when it 
counts because, unlike aversive racist decisions in hiring, aversive racism in physicians’ 
treatment recommendations hastens morbidity and mortality for patients. But how can aversive 
racism be eliminated? Gaertner and Dovidio [12] suggest that employing techniques such as 
creating a common group identity by shifting the axis of identification from race to some shared 
characteristic like nationality or gender, might be one way of reducing aversive racism.  
Additional measures to reduce this type of bias include the inducement of aversive racists to 
become aware of the discrepancy between their beliefs and their actions, practicing ways to align 
their actions more closely with their egalitarian beliefs. Aversive racists may also reduce the 
tendency to discriminate when they are consciously reminded of the potential influence of 
aversive racism on their decision making or are reminded of a past situation in which they 
discriminated against African Americans. Finally, increasing quality interactions with out-group 
members, especially for those aversive racists with very little out-group contact, may influence 
reductions in both implicit and explicit biases [13].  
 
Further Research 
Future research on health disparities should explore the issue of over compensation in 
depth. Physicians, like most liberals, see racism as a threat to their self-image and may provide 




diminished are: in the application of the Implicit Association Test and in the choice of explicit 
bias measures. The employment of indirect measures of discriminatory belief may be useful in 
reducing anxiety around racism. For example, an IAT contrasting urban and suburban regions or 
common black stereotypes (e.g., food stamp receipt; welfare; laziness) may elicit more natural 
responses than pictures of white and black faces, especially among younger participants.   I state 
this not to question  the IAT’s ability to truly measure implicit bias, but to highlight the potential 
impact of the IAT on anxiety levels around race and racism
38
.  In the same way, explicit 
discriminatory items using less reactive items as proxies for racist beliefs may be more useful for 
younger respondents who are sensitized to issues of race and racism. In addition, future study 
vignettes should provide physician respondents with prior information on their patient’s lab 
results and disease activity  and should use video presentations where possible in order to enable 
physicians to better assess patients’ personal characteristics. 
Kwate also suggests that “future research should continue to specify the domain of 
observables for the construct of racism, and develop or refine [perceived racism] scale items to 
attend more closely to experiences of gendered stigma”[100]. There is additionally a need to 
focus on women’s health outcome as separate and different from men’s. The results of studies 
into diseases that affect men and women fairly equally have shown gender and racial bias in 
treatment recommendations [61, 62], but either have focused on the expressions of these 
disparities as though race and gender are mutually exclusive or have failed to delve deeply into 
the inter-sectorial nature of race and gender in their findings. Thus, the specific experience of 
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black women and other women of color with physician-mediated health disparities has been 
overlooked
39
.  Future research should focus not only on understanding how health disparities 
function for women patients, particularly those with chronic illnesses that affect women 
disproportionately, but also on the creation of methods to reduce disparities specific to these 
diseases that go beyond cultural sensitivity training. In the case of SLE, a set of 20 quality 
indicators for the treatment of SLE was created in 2009 [161] that include indications for 
prescription and testing for a variety of common SLE manifestations and symptoms, including 
LN. Were rheumatologists and family practitioners/general practitioners to be required to justify 
reasons for not following these and other guidelines in prescription and testing recommendations 
for all patients, the freedom of these physicians to differentiate treatment without justification 
would be constrained.  Similarly, Bornstein and Emler suggest that by “providing the most 
relevant and objective empirical information available, and incorporating it with clinical 
expertise, test results and patient preferences, many of the biases associated with doctors’ relying 
too heavily on intuition and selectively attending to some information while ignoring other 
relevant information could be avoided” [162]. They also recommend the use of decision analytic 
aids, often computerized, to improve physicians’ decision-making performance.  I see a need for 
these tools, both the sharing of evidence and the use of decision aids, as essential to reducing 
health disparities for black women with SLE.  
Finally, 20 more years of research into health disparities without the financing and 
implementation of empirically-based interventions will do little to reduce health disparities. The 
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research community must translate the current body of studies into working agenda for piloting 
models of physician-led disparity reduction programs.  These programs should test the feasibility 
of the recommendations above: the use of accountability systems; sharing of up-to-date empirical 
evidence with clinicians; and the use of diagnostic aids. They should also employ a gender focus 
in their design: both physicians treating diseases common to the general population and those 
treating “women’s” illnesses need to understand the implications of both the physician’s 
interaction style and the impact of the disease and its treatment on both women and men in order 
to make recommendations that will enhance compliance [163]. Government programs in 
countries with national health systems and even the U.S.’ Patient Protection and Affordable Care 
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APPENDIX 1. SURVEY QUESTIONNAIRE 
  
Instructions: Thank you for agreeing to participate in this research. This research study is an 
experiment divided into 2 parts: i) this 2-page survey and ii) a test of association, followed by 
some questions about you and about the study. The study (parts one and two) should take you 
between 10 and 12 minutes to complete. Use the scroll bar to the immediate right of this test to 
maneuver through the survey. 
For this survey, you are asked to answer the demographic questions below, read the case vignette 
you will be given and answer the series of questions presented about your treatment decisions 
and your “patient’s” characteristics. Please read and follow the directions given at the beginning 
of each section. You may begin.  
Part 1: Section 1  
Instructions: The following are questions about you and your medical practice. Please respond to 
the best of your ability to all of the questions. Remember that this study will collect no 
identifying information about you: 
1. In what country is your current primary medical practice located?  ____________________ 
2. In which country were you born?: __________________________________ 
3. What is your gender?:   1. Female  
2. Male   
3. Other 
4. What is your race as you would declare it on the United States Census? (Please remember that 
race is different from ethnicity. You will be given an opportunity to indicate your ethnicity in the 
next question item): 1. American Indian or Alaska Native 
   2. Asian 
   3. Black or African American 
   4. Native Hawaiian or Other Pacific Islander 
   5. White 
   6. Some Other Race 
5. What is your ethnicity? (You may choose more than one):   
1. East African 
2. West African 
3. Central African 
4. Southern African 
5. North American (USA or Canada) 




7. South Asian 
8. Southeast Asian 
9. Brazilian 
10. Eastern European 
11. Western European 
12. Southern European 
13. Hispanic/Latino (Western Hemisphere Spanish-speaking) 
14. Caribbean (English-/French-speaking) 
15. Middle Eastern/North African 
16. Pacific Islander 
17. Other Ethnicity (or explain response above) 
 
6. Which category below includes your age?: 1. 20-29 
       2. 30-39 
       3. 40-49 
       4. 50-59 
       5. 60 and above 
7. Are you a physician (MD or DO)?:  1. Yes 
      2. No 
 
8. What is your medical specialty?:  1. Rheumatology 
     2. Internal medicine 
     3. Pediatrics (Pediatric Rheumatology) 
     4. Dermatology 
     5. Nephrology 
     6. Other specialty (specify) 
 
9. Approximately what percentage of your total current patient load: i. have you diagnosed with 
Systemic Lupus Erythematosus (SLE) and/or; ii. was diagnosed with SLE by another physician 
prior to coming under your care?: 1. Fewer than 10% 
     2. 10%-30% 
     3. 31%-50% 
     4. 51%-70% 
     5. 71%-90% 
     6. 91%-100%   
10. In what type of medical setting do you see the majority (>60%) of your patients?:  
1. Private office/private clinic 
2. Hospital-/university-based clinic 
3. Other public clinic 




5. Other setting (specify) 
 







8. 1949 or before 
 
12. Did you graduate from a clinical training (fellowship) program?:  1. Yes 
          2. No 
13. If yes, in what specialty?: 1. Rheumatology 
     2. Cardiology 
     3. Nephrology 
     4. Orthopedics 
     5. Hematology 
     6. Other (specify) 
 
14. How long have you held your position in your current (most recent) medical practice?:
 1. Less than 1 year 
 2. 1 year – 5 years  
3. 5years –10 years  
4. 10years – 20years   
5. More than 20 years 
 
15. Why have you decided to participate in this study?: ________________________________ 
______________________________________________________________________________ 
 
[Vignette with patient, Julia’s, photos presented here. Selection of symptom and patient race is 
random. See Figures 4 and 5 in main text.] 
 
Part 1: Section 2 
Instructions: Please read the vignette above if you have not done so already, then respond to the 




16. I would make the following recommendations for Julia: 
16a. I recommend:  Prescriptions:  1. no changes in medication  
2. increase oral corticosteroids 
3. start intravenous corticosteroids  
4. start NSAIDs  
5. start oral immunosuppressives (e.g., methotrexate) 
6. start intravenous cytotoxic agents (e.g., rituximab) 
 
16b. I have chosen none of the options above. Instead, I recommend the following: 
_______________________________________________________________ 
16c. If in Question 16a you recommended an oral corticosteroid, NSAIDs or oral 
immunosuppresants, what   dose and frequency would you prescribe? 
_______________________________________________ 
17. I would make the following recommendations for Julia:  
17a. I recommend: Medical Testing:   1. no testing 
2. urinalysis 
3. MRI 
     4. renal biopsy  
5. cardiac stress testing  
6. renal replacement  
 
17b. I have chosen none of the options above. Instead, I recommend the following: 
_______________________________________________________________ 
18. I would make the following recommendations for Julia:  
18a. I recommend: Specialist referral:  1. no referral 
2. cardiologist 
3. pulmonologist  
4. nephrologist  
5. dermatologist 
6. infectious disease specialist 
 





19. I would make the following recommendations for Julia: 
19a. I recommend: Time to next appointment with me:  1. Less than 1 month 
        2. 1-3 months 
        3. 3-6 months 
        4. 6-9 months 
        5. 9 months – 1 year 
 
19b. I have chosen none of the options above. Instead, I recommend the following: 
_______________________________________________________________ 
20.  Please comment on the availability (ease of attaining the service for a patient with the most 
common health insurance that you see in your practice) of the following SLE treatments for 
patients in your practice on a scale ranging from “not at all available” to “very commonly 
available”: 











Oral corticosteroids      
Intravenous 
corticosteroids      
NSAIDs      
Oral 
chemotherapeutic 
agents      
Intravenous 
chemotherapeutic 
agents      
Magnetic Resonance 
Imaging (MRI)      
Renal biopsy      




Hemodialysis      
Peritoneal Dialysis      
Renal Transplant      
  
Section 3: Please rate your patient, Julia, using the following scales.  
Please rate your patient using the following scale where -3 is equivalent to an extreme of the 
description to the left of the hyphen and +3 is equivalent to an extreme of the description to the 
right. 
 21. I consider this patient to be:  
     Hostile (-
3) 
-2 -1 0 +1 +2 Friendly 
(+3) 
Hostile - Friendly         
 
22. I consider this patient to be: 
 Unintelligent(-
3) 
-2 -1 0 +1 +2 Intelligent 
(+3) 
Unintelligent – Intelligent        
 
23. I consider this patient to be: 
 Lacking self-
control (-3) 
-2 -1 0 +1 +2 Self-
controlled 
(+3) 
Lacking Self-control - Self-
controlled        
 
24. I consider this patient to be: 




2 ble (+3) 
Ignorant – Knowledgeable        
 









Poor communicator – Good 
communicator  
       
 
26. I consider this patient to be: 




Dependent – Independent        
 
27. I consider this patient to be: 




Sad – Happy        
 














29. I consider this patient to be: 
 Worried 
 (-3) 




Worried – Indifferent        
 




-2 -1 0 +1 +2 High 
SES 
(+3) 
Low Socioeconomic Status – High 
Socioeconomic Status 
       
 
 
Please answer the following questions about your patient, Julia. Please use the following scale 
where 1 is “very unlikely” and 5 is “very likely.” For the final question the scale is 1 “much less 
than average” to 5 “greater than average.” 
31. I consider this patient: 
 very unlikely 
(1) 
2 3 4 very likely 
(5) 
Likely to over-report symptoms      
Likely to miss appointments       
Likely to participate      
Likely to complain to higher authorities 
about treatment      





32. I consider this patient: 
 much less 
than the 
average 





Likely to benefit from an invasive 
procedure(s) 
     
 
33. Of which race is your patient, Julia? (choose only one). Please remember that race is 
different from ethnicity. The US Census recognizes the following ethnicities: Hispanic and non-
Hispanic.:     
 
1. American Indian or Alaska Native 
 2. Asian 
 3. Black or African American 
 4. Native Hawaiian or Other Pacific Islander 
 5. White 
 6. Some Other Race (specify) 
 
34. Please create a unique identification number between 4 and 6 digits. You will be asked to 
enter this number to begin Part Two of the study. Please avoid using only one digit (e.g., 5555) 
or a series of sequential numbers (e.g., 12345; 6789) as the id. It is suggested that you write 
down the number you choose.  
____________________. 
Thank you for your responses. Please click the “DONE” button below then scroll up using the 
outermost scroll bar on Armbristerdissertationsite.com to find the “Association Test” tab that 
will take you to the next and last section. If you have left the study website to complete this 






APPENDIX 2. EXPLICIT BIAS ITEMS 
 
35. Please state your agreement with the following statements, where -3 is equivalent to 
“strongly disagree” and +3 is equivalent to “strongly agree.” 
 strongly 
disagree (-








It’s OK if some groups have more of a chance in 
life than others.        
Inferior groups should stay in their place.        
We should do what we can to equalize 
conditions for different groups        
We would have fewer problems if we treated 
people more equally        
In today’s society it is important that one not be 
perceived as prejudiced in any manner.        
I feel it’s important to behave according to my 
society’s standards.        
I’m careful not to offend my friends, but I don’t 
worry about offending people I don’t know or 
don’t like.         
I’m not afraid to tell others what I think, even 










36. Please state your agreement with the following statements, where -2 is equivalent to 
“strongly disagree” and +2 is equivalent to “strongly agree.” 
 strongly 
disagree (-






Discrimination against blacks is no longer a 
problem in the United States.      
Blacks should not push themselves where they 






APPENDIX 3. STUDY WEBSITE SCREEN SHOTS 
 
(Click on any photo to access web page hyperlink.)  
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